syndrome	score	normalized_score
DRAVET SYNDROME	2.6961448399999997	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52620533	56.60694883142852
MYOCLONIC-ASTASTIC EPILEPSY	1.223545494	45.381296874243596
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.27410509592652
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	42.89185739739413
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	1.154907149	42.835500966632054
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	1.077468654	39.96330753506552
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.089995506324506
EHLERS-DANLOS SYNDROME, TYPE I	1.0	37.089995506324506
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.089995506324506
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	34.65840358932646
LAFORA DISEASE	0.7715289599999999	28.616005659399217
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.582184776096824
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.754426914	27.98169085011026
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.286752235462245
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.680345954	25.23402837660606
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.60048818	22.272103897800985
ROLANDIC EPILEPSY	0.59608578	22.10881890158394
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5818714	21.58160761125875
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5552362999999999	20.593711871948244
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	19.78131857337457
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.54742906171169
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.5202834940000001	19.297312454474817
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.806194774016667
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.565232348570714
MALIGNANT ATROPHIC PAPULOSIS	0.500541419	18.565078981439296
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.500541419	18.565078981439296
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.544997753162253
INHALATIONAL ANTHRAX	0.5	18.544997753162253
RESTRICTIVE DERMOPATHY	0.5	18.544997753162253
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	18.544997753162253
BRANCHIOOTORENAL SYNDROME 1	0.5	18.544997753162253
PAROXYSMAL HEMICRANIA	0.5	18.544997753162253
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.544997753162253
CREST SYNDROME	0.5	18.544997753162253
NEUROMYELITIS OPTICA	0.44444399999999995	16.48442596281289
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43744392000000004	16.22479302706898
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42505119	15.765146727057886
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.420979254	15.614118639115846
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.165776479575188
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40130846000000003	14.88452897805001
SPINOCEREBELLAR ATAXIA TYPE 42	0.3888886	14.42387642646083
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.521525423686068
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.357858224	13.27295992006127
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.260328402831654
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.260328402831654
CENTRALOPATHIC EPILEPSY	0.3547009	13.155854787089257
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.34968319400000003	12.969748094097202
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.789643007458013
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34381168	12.75197366622188
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.706745383901557
SPINOCEREBELLAR ATAXIA TYPE 12	0.34210493	12.688670316391459
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34173636	12.675000056747695
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.33933889899999997	12.586078239031107
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.33676943	12.490776645367466
EPIDERMAL NEVUS SYNDROME	0.333878554	12.383554067518125
COG4-CDG	0.333878554	12.383554067518125
POSTENCEPHALITIC PARKINSONISM	0.333874419	12.383400700386705
PLACENTAL INSUFFICIENCY	0.333333	12.363319472109668
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.363319472109668
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.363319472109668
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.333333	12.363319472109668
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.32818681	12.172447308134975
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.174526291399092
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.283864954	10.528549868263013
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.281167559	10.428503499834232
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.281167559	10.428503499834232
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.27431560000000005	10.174364371314713
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.259940294	9.641184336372673
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.254851759	9.452450596088898
GM2 GANGLIOSIDOSIS, AB VARIANT	0.254851759	9.452450596088898
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.251086973	9.312814700266623
PALLISTER-HALL SYNDROME	0.250545554	9.292733471989585
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.250545554	9.292733471989585
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.250545554	9.292733471989585
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.272498876581126
HYPEREKPLEXIA 1; HKPX1	0.25	9.272498876581126
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.25	9.272498876581126
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.272498876581126
HYPERPARATHYROIDISM 2	0.25	9.272498876581126
DYSTONIA 6, TORSION	0.25	9.272498876581126
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24444441	9.066442068446145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.014543669693948
LENNOX-GASTAUT SYNDROME	0.23841926	8.842969282021215
TRICHOTHIODYSTROPHY	0.237582554	8.8119358602411
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.701862026077206
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.23387798000000004	8.674533227228256
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.379711158247718
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.21308991693488
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.216847064	8.042856629319663
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.610433124950365
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20343643	7.545456274522701
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20343643	7.545456274522701
ROMANO-WARD SYNDROME	0.200541419	7.438080329541941
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.417999101264902
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.417999101264902
BENIGN SCHWANNOMA	0.2	7.417999101264902
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	7.417999101264902
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	7.417999101264902
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.417999101264902
MALARIA	0.2	7.417999101264902
POLYARTERITIS NODOSA	0.2	7.417999101264902
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.19106063399999998	7.086438056495512
MYOCLONIC EPILEPSY OF INFANCY	0.19106063399999998	7.086438056495512
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.18301719400000002	6.788106903040121
ISAAC SYNDROME	0.18279600000000001	6.779902818574096
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17920148399999997	6.646582236286683
PFAPA SYNDROME	0.17543893000000002	6.50702912533438
UNILATERAL POLYMICROGYRIA	0.17540911	6.505923101668381
MUCOLIPIDOSIS TYPE II	0.17407441	6.4564190846660905
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.172064313	6.381864595968814
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.168952704	6.2664550321413754
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16846645399999996	6.248420021826423
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	6.201759509329626
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.201759509329626
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.181678281052587
ADULT-ONSET NEMALINE MYOPATHY	0.166667	6.181678281052587
DERMATOLEUKODYSTROPHY	0.166667	6.181678281052587
PITYRIASIS RUBRA PILARIS	0.166667	6.181678281052587
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.181678281052587
SPINOCEREBELLAR ATAXIA TYPE 18	0.166667	6.181678281052587
PEMPHIGUS VULGARIS	0.166667	6.181678281052587
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	6.181678281052587
CEREBROOCULONASAL SYNDROME	0.166667	6.181678281052587
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.166667	6.181678281052587
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.166667	6.181678281052587
RIDDLE SYNDROME	0.16125965399999997	5.981119842211444
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.916065696233145
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.916065696233145
COMBINED SAPOSIN DEFICIENCY	0.158986	5.896790025568508
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1587945	5.8896872914290475
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.15604529	5.787719104883105
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15457474999999998	5.733176782891234
TUBEROUS SCLEROSIS COMPLEX	0.15391778	5.7088097685434445
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.662225995247347
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.662225995247347
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.622528053796992
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.15077671	5.592307496358393
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.519347395297948
NEPHROGENIC DIABETES INSIPIDUS	0.14394397299999998	5.338881311732496
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.318800083455457
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.14339841899999997	5.318646716324038
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.14285699999999998	5.298565488046999
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.14285699999999998	5.298565488046999
POSTERIOR URETHRAL VALVE	0.14285699999999998	5.298565488046999
TORIELLO-LACASSIE-DROSTE SYNDROME	0.14285699999999998	5.298565488046999
%600631 ENURESIS, NOCTURNAL, 1; ENUR1;;BEDWETTING	0.14285699999999998	5.298565488046999
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	5.298565488046999
PENILE AGENESIS	0.14285699999999998	5.298565488046999
%600808 ENURESIS, NOCTURNAL, 2; ENUR2	0.14285699999999998	5.298565488046999
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.298565488046999
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	5.298565488046999
MULTIPLE MYELOMA	0.14285699999999998	5.298565488046999
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.13870195000000002	5.1444547022184475
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.13432305	4.982041320895803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12522615399999998	4.6446374891343005
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.12315085399999999	4.567664621460025
ZELLWEGER SYNDROME	0.12158217900000001	4.509482472759142
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.402538106966094
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.382303511557636
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.375252703411884
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.11596689399999999	4.30121157734241
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.11219797299999999	4.161422314388719
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.11219797299999999	4.161422314388719
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.11219797299999999	4.161422314388719
XQ28 (MECP2) DUPLICATION	0.11219797299999999	4.161422314388719
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.11111099999999999	4.121106490703222
X-LINKED IMMUNONEUROLOGIC DISORDER	0.11111099999999999	4.121106490703222
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.11111099999999999	4.121106490703222
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.11111099999999999	4.121106490703222
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	4.121106490703222
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.11111099999999999	4.121106490703222
DYSTONIA 16; DYT16	0.11111099999999999	4.121106490703222
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.11111099999999999	4.121106490703222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.111069204	4.11955627725104
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10714290000000001	3.973929679534577
SCHINZEL-GIEDION SYNDROME	0.10714290000000001	3.973929679534577
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.106797214	3.9611081873479765
BILATERAL POLYMICROGYRIA	0.104660764	3.88186726644849
AICARDI SYNDROME; AIC	0.1036867	3.845739237065618
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.09929760000000001	3.682947537788809
GITELMAN SYNDROME	0.09903390000000001	3.6731669059737913
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.098986104	3.671394152548571
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.6701701826968622
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.64942760270995
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.64942760270995
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.6393389755722474
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.6393389755722474
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.6393389755722474
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.6393389755722474
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.6393389755722474
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.0955556	3.5441567746041422
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0941662	3.4926239348476553
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.09229817	3.4233387105419752
ADNP SYNDROME	0.09164844899999999	3.399240561571611
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.09143153999999999	3.391195407736329
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.08927881000000001	3.3113506617100006
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.08672729400000001	3.2167149447356853
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.086236449	3.198509505891383
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.1965033451244413
SPINOCEREBELLAR ATAXIA TYPE 36	0.08540178	3.1675516364321146
CONGENITAL ENTEROVIRUS INFECTION	0.08532646	3.164758017970578
BECKWITH-WIEDEMANN SYNDROME	0.08532646	3.164758017970578
CLASSICAL EHLERS-DANLOS SYNDROME	0.08532646	3.164758017970578
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.08521128900000001	3.1604863260981193
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.083878954	3.1110700269352005
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.083474553	3.0960707956624476
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.08339244399999998	3.0930253732214177
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08269673	3.067221344087731
SALT-AND-PEPPER SYNDROME	0.082384474	3.055639770450908
ETHYLMALONIC ENCEPHALOPATHY	0.081774859	3.0330291528403204
AICARDI SYNDROME	0.08133220999999999	3.016611303419441
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08123344	3.0129479245632815
DDOST-CDG	0.08090094900000001	3.000615834867389
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.08035953000000001	2.98053460659035
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.0799373	2.9648740977877144
SPINAL MUSCULAR ATROPHY, TYPE II	0.0799373	2.9648740977877144
SPINAL MUSCULAR ATROPHY, TYPE IV	0.0799373	2.9648740977877144
DUPLICATION OF THE PITUITARY GLAND	0.07746865400000001	2.8733120287410086
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.8733120287410086
OROFACIODIGITAL SYNDROME TYPE 4	0.07746865400000001	2.8733120287410086
TRISOMY 8P	0.07746451900000001	2.87315866160959
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.07746451900000001	2.87315866160959
NORMOKALEMIC PERIODIC PARALYSIS	0.07692310000000001	2.853077433332551
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	2.853077433332551
MALAKOPLAKIA	0.07692310000000001	2.853077433332551
TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF	0.07692310000000001	2.853077433332551
RHIZOMELIC SYNDROME, URBACH TYPE	0.07692310000000001	2.853077433332551
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.853077433332551
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.853077433332551
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.853077433332551
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.07692310000000001	2.853077433332551
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.07692310000000001	2.853077433332551
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.853077433332551
AMISH INFANTILE EPILEPSY SYNDROME	0.07641829	2.834354032701003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07628449400000001	2.8293915396622396
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.07533176	2.7940546398835164
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.7493979143939464
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.7077195155435345
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.703623667339771
9P13 MICRODELETION SYNDROME	0.07220537999999999	2.6780972197324533
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.6695210484315086
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.071749723	2.6611969036500285
HYPERLYSINEMIA, TYPE I	0.069742169	2.586736734811325
YOU-HOOVER-FONG SYNDROME; YHFS	0.068517954	2.54133060596255
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.068513819	2.541177238831131
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.4929021988299414
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.4927488316985227
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.066800863	2.4776437084885994
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.472667603421484
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.472667603421484
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.472667603421484
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.472667603421484
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.472667603421484
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.472667603421484
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.472667603421484
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.472667603421484
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.472667603421484
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.472667603421484
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.472667603421484
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.472667603421484
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.472667603421484
WHITE-SUTTON SYNDROME; WHSUS	0.064873084	2.4061423940414124
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4039806407433217
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.06403056399999998	2.3748933310274234
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.063847924	2.368119214248149
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0627413	2.327074535060958
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.321753975205576
PELIZAEUS-MERZBACHER DISEASE	0.06202704900000001	2.3005829686805703
NORMAL PRESSURE HYDROCEPHALUS	0.0607986	2.255019800790821
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.060411494	2.24066204099035
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.060277359999999995	2.2356870115331042
49,XYYYY SYNDROME	0.059523799999999995	2.2077374745193588
49,XXXYY SYNDROME	0.059523799999999995	2.2077374745193588
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.05899203	2.1880141276089606
DISTAL MONOSOMY 10Q	0.058433113	2.1672838985905525
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.05815019	2.1567902857919163
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.058064029	2.153594574689096
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.05802693	2.1522185729458068
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0578571	2.145919579008968
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.142982422264822
RFT1-CDG	0.056642573	2.100872778036658
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.056642573	2.100872778036658
HISTIDINEMIA	0.056286579999999996	2.087668999266375
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.056097019000000005	2.0806381826282005
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.056097019000000005	2.0806381826282005
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.060556954351162
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.060556954351162
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.055555600000000004	2.060556954351162
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.060556954351162
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.060556954351162
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.060556954351162
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.055555600000000004	2.060556954351162
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.055555600000000004	2.060556954351162
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.060556954351162
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.060556954351162
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.060556954351162
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.060556954351162
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.055555600000000004	2.060556954351162
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.060556954351162
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.060556954351162
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.060556954351162
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.060556954351162
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.060556954351162
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.054924803999999994	2.0371607335457544
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05453859	2.0228360580212748
CITRULLINEMIA TYPE II	0.053849653	1.997283387787134
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.053742689	1.9933160935077958
MENTAL RETARDATION, X-LINKED 90	0.053337203	1.9782766195899182
PANDAS	0.05325312000000001	1.97515798149776
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.053166	1.9719267010892487
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.05249174	1.9469184007191547
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.051848003999999996	1.923042235371895
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9020199968188656
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.8983074737186603
XQ12-Q13.3 DUPLICATION SYNDROME	0.05092595999999999	1.8888436275552614
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.050851813	1.8860935156584542
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0506118	1.8771914345669949
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.050310394	1.8660122873814158
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.050029753	1.8556033139525252
7Q11.23 MICRODUPLICATION SYNDROME	0.049867669	1.8495916191208783
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.049114714000000004	1.8216645215544134
WILLIAMS-BEUREN SYNDROME; WBS	0.048942780000000005	1.8152874902670293
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.048875613000000005	1.8127962665388562
CHRISTIANSON SYNDROME	0.04875475	1.8083134584119749
DISTAL MONOSOMY 12Q	0.048060203999999995	1.7825527503930392
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04804403	1.78195285680572
XP22.13P22.2 DUPLICATION SYNDROME	0.047672598999999996	1.7681764826848103
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.047119103999999995	1.747647355622037
SMITH-MAGENIS SYNDROME; SMS	0.046934922999999996	1.7408160831596866
KOOLEN-DE VRIES SYNDROME; KDVS	0.046934922999999996	1.7408160831596866
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7323906085104837
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.046541473	1.7262230244277235
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.046541473	1.7262230244277235
HAMAMY SYNDROME; HMMS	0.04597704	1.705288206994102
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.7045337964855034
NEURONAL CEROID LIPOFUSCINOSIS	0.045881789	1.7017553478321295
NON-DISTAL MONOSOMY 20Q	0.045671408999999996	1.6939523545775086
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0454545	1.6859072007422273
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.0454545	1.6859072007422273
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0454545	1.6859072007422273
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.0454545	1.6859072007422273
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0454545	1.6859072007422273
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0454545	1.6859072007422273
HUNTINGTON DISEASE	0.04534037	1.6816741195550904
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.045148299999999995	1.6745502441181905
300270 ADRENOMYODYSTROPHY	0.044989964	1.6686775625897017
MICROHYDRANENCEPHALY; MHAC	0.04497356	1.6680691383034159
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6662869640193367
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.044565273	1.6529257753081252
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.044565273	1.6529257753081252
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.6484429671812442
PYRIDOXINE-DEPENDENT EPILEPSY	0.044297953999999994	1.6430109147993694
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.6430109147993694
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.044023854	1.6328445470310864
GITELMAN SYNDROME	0.044019719000000006	1.6326911798996677
LISSENCEPHALY, X-LINKED, 2	0.04366312900000001	1.6194652584020677
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04366312900000001	1.6194652584020677
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04366312900000001	1.6194652584020677
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04359198	1.616826342311788
ENAMEL-RENAL SYNDROME	0.043478300000000004	1.6126099516226293
SENIOR-LOKEN SYNDROME 3	0.043478300000000004	1.6126099516226293
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.043478300000000004	1.6126099516226293
PRIMARY HYPEROXALURIA TYPE 1	0.043478300000000004	1.6126099516226293
UROFACIAL SYNDROME 2	0.043478300000000004	1.6126099516226293
POSTERIOR MENINGOCELE	0.043478300000000004	1.6126099516226293
UROFACIAL SYNDROME	0.043478300000000004	1.6126099516226293
HINMAN SYNDROME	0.043478300000000004	1.6126099516226293
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.043254730000000005	1.60431774132728
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6040960915141338
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.599384030125029
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.5858402473659394
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5858402473659394
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.5858402473659394
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.5838614961056767
MENTAL RETARDATION, X-LINKED 98; MRX98	0.042613883000000005	1.5805487289770386
COG2-CDG	0.04221225399999999	1.5656523111718286
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042208118999999995	1.56549894404041
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042208118999999995	1.56549894404041
PGM3-CDG	0.042208118999999995	1.56549894404041
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.042208118999999995	1.56549894404041
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.56549894404041
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04202195399999999	1.558594085026975
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041724334	1.547555360564383
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.041676284	1.5457731862803041
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.5454177157633713
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.5454177157633713
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5454177157633713
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	1.5454177157633713
ISOLATED CEREBELLAR AGENESIS	0.041571448999999996	1.5418848566013985
MERRF	0.041517359999999996	1.5398786958344568
CANAVAN DISEASE	0.04134734	1.5335726547984718
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.04134734	1.5335726547984718
DIENCEPHALIC SYNDROME	0.041030029999999995	1.5218036283243597
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	1.5218036283243597
LESCH-NYHAN SYNDROME	0.041030029999999995	1.5218036283243597
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.04102835	1.5217413171319092
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.040876303999999995	1.5161019316751545
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.040860070000000005	1.515499812688105
CONGENITAL ANALBUMINEMIA	0.040661459999999996	1.5081333686805936
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.04056605900000001	1.5045949460192953
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.040559953999999995	1.5043685115967285
TRISOMY 12P	0.040545554	1.5038344156614376
KAPUR-TORIELLO SYNDROME	0.040541419	1.5036810485300192
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.04033075	1.4958673362666972
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	1.4835998202529803
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.4835998202529803
ALKAPTONURIA	0.04	1.4835998202529803
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04	1.4835998202529803
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.4835998202529803
3Q13 MICRODELETION SYNDROME	0.04	1.4835998202529803
MECKEL SYNDROME, TYPE 5	0.04	1.4835998202529803
NON-DISTAL TRISOMY 10Q	0.04	1.4835998202529803
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.04	1.4835998202529803
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.4835998202529803
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.4835998202529803
BLACKFAN-DIAMOND ANEMIA	0.04	1.4835998202529803
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.4835998202529803
COCAINE EMBRYOFETOPATHY	0.04	1.4835998202529803
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.4835998202529803
SARCOSINEMIA	0.039845903999999994	1.4778844003054377
ALPERS-HUTTENLOCHER SYNDROME	0.039675944	1.4715805846691827
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.039176004	1.453037812315751
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.039007054	1.4467714575749575
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038925144	1.4437334160430346
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4287548438977782
BAZEX SYNDROME; BZX	0.0384615	1.4265368621665002
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4265368621665002
LIP, HAMARTOMATOUS	0.0384615	1.4265368621665002
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4265368621665002
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4265368621665002
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4265368621665002
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4265368621665002
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4265368621665002
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4265368621665002
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	1.4265368621665002
CYCLIC NEUTROPENIA	0.0384615	1.4265368621665002
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4265368621665002
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.4265368621665002
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4265368621665002
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4265368621665002
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4265368621665002
MAL DE MELEDA	0.0384615	1.4265368621665002
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4265368621665002
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.4265368621665002
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03837959	1.4234988206345771
TUBEROUS SCLEROSIS-1	0.038263999	1.4192115509640055
TUBEROUS SCLEROSIS 2; TSC2	0.038263999	1.4192115509640055
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03825648	1.4189326712877937
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4050899431649229
LISSENCEPHALY 2; LIS2	0.037582554	1.3939367589761982
16P13.11 MICRODELETION SYNDROME	0.037582554	1.3939367589761982
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.3939367589761982
VISCERAL STEATOSIS, CONGENITAL	0.037578419	1.3937833918447795
MUCOPOLYSACCHARIDOSIS TYPE 2	0.037561063	1.3931396578827717
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.037561063	1.3931396578827717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.037422529999999996	1.388001469535294
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.037113294000000005	1.3765319076849005
ATYPICAL RETT SYNDROME	0.037109859	1.376404503550336
FLYNN-AIRD SYNDROME	0.037109859	1.376404503550336
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.037109858999999995	1.376404503550336
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.3737021635677409
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.3737021635677409
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3737021635677409
SCIMITAR SYNDROME	0.037037	1.3737021635677409
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.3737021635677409
GENITOURINARY TRACT ANOMALIES	0.037037	1.3737021635677409
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.037037	1.3737021635677409
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.3737021635677409
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.3737021635677409
MYOCLONUS AND ATAXIA	0.037037	1.3737021635677409
MCLEOD SYNDROME; MCLDS	0.037037	1.3737021635677409
ADENOMYOSIS	0.037037	1.3737021635677409
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.3737021635677409
URINARY BLADDER, ATONY OF	0.037037	1.3737021635677409
GALACTORRHEA	0.037037	1.3737021635677409
PEYRONIE DISEASE	0.037037	1.3737021635677409
NATHALIE SYNDROME	0.037037	1.3737021635677409
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.3737021635677409
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.3737021635677409
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.3737021635677409
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3737021635677409
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.3737021635677409
DK PHOCOMELIA SYNDROME	0.037037	1.3737021635677409
TESTICULAR TORSION	0.037037	1.3737021635677409
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.3737021635677409
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3737021635677409
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.036801273	1.3649590501970215
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036801273	1.3649590501970215
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.3649590501970215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036801273	1.3649590501970215
3P25.3 MICRODELETION SYNDROME	0.03669139	1.3608834902208
WEST SYNDROME	0.03656844	1.3563232752732974
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.036255719000000006	1.3447244547885644
SLC39A8-CDG	0.036255719000000006	1.3447244547885644
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.036255719000000006	1.3447244547885644
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.036255719000000006	1.3447244547885644
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.036255719000000006	1.3447244547885644
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.036255719000000006	1.3447244547885644
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.036255719000000006	1.3447244547885644
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.036235948999999996	1.3439911855774038
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.3246432265115256
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3228610522274464
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3228610522274464
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.035569773	1.3192827207309827
HSD10 DISEASE	0.035149543000000005	1.3036963919193603
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.035028354	1.2992014924539441
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.035028354	1.2992014924539441
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.035028354	1.2992014924539441
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.035028354	1.2992014924539441
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.035024219	1.2990481253225257
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.035024219	1.2990481253225257
DOORS SYNDROME	0.034614804	1.2838629248123037
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.034531653999999995	1.2807788916859526
SPINOCEREBELLAR ATAXIA TYPE 27	0.0344828	1.2789668970454868
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.0344828	1.2789668970454868
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.0344828	1.2789668970454868
DYSTONIA 7, TORSION	0.0344828	1.2789668970454868
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.0344828	1.2789668970454868
TREMOR, HEREDITARY ESSENTIAL, 1	0.0344828	1.2789668970454868
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0344828	1.2789668970454868
X-LINKED DYSTONIA-PARKINSONISM	0.0344828	1.2789668970454868
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0344828	1.2789668970454868
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.2771721121629358
15Q13.3 MICRODELETION SYNDROME	0.034329253000000004	1.2732718395054772
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2636283294038462
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.033787834	1.2531906112284386
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.033345072999999996	1.2367686077280626
WOLF-HIRSCHHORN SYNDROME	0.033345072999999996	1.2367686077280626
CHROMOSOME 1P36 DELETION SYNDROME	0.033345072999999996	1.2367686077280626
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.2367686077280626
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.033250722999999996	1.2332691666520408
CHROMOSOME 10Q26 DELETION SYNDROME	0.033250722999999996	1.2332691666520408
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.2166873794510238
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.2166873794510238
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.2166873794510238
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.032803653999999995	1.2166873794510238
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2166873794510238
PEHO SYNDROME	0.032803653999999995	1.2166873794510238
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	1.2166873794510238
SLC35A2-CDG	0.032803653999999995	1.2166873794510238
LEIGH SYNDROME	0.032799519	1.2165340123196053
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2165340123196053
OCULODENTODIGITAL DYSPLASIA	0.032799519	1.2165340123196053
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2165340123196053
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2165340123196053
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.032799519	1.2165340123196053
SANDHOFF DISEASE	0.032799519	1.2165340123196053
DEND SYNDROME	0.032799519	1.2165340123196053
BRAIN-LUNG-THYROID SYNDROME	0.032709303999999995	1.2131879383750022
WIEDEMANN-STEINER SYNDROME	0.032705169	1.2130345712435837
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.032705169	1.2130345712435837
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.032705169	1.2130345712435837
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0322581	1.1964527840425665
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.1964527840425665
DYSTONIA, JUVENILE-ONSET	0.0322581	1.1964527840425665
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	1.1964527840425665
MILD CANAVAN DISEASE	0.0322581	1.1964527840425665
ATTENUATED CHÃ‰DIAK-HIGASHI SYNDROME	0.0322581	1.1964527840425665
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.1964527840425665
DENT DISEASE	0.0322581	1.1964527840425665
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.1964527840425665
SECKEL SYNDROME 2; SCKL2	0.0322581	1.1964527840425665
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.1964527840425665
ISOTRETINOIN-LIKE SYNDROME	0.0322581	1.1964527840425665
ALG13-CDG	0.0322581	1.1964527840425665
SECKEL SYNDROME	0.0322581	1.1964527840425665
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.1964527840425665
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.1964527840425665
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.1964527840425665
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	1.1964527840425665
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.1964527840425665
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0322581	1.1964527840425665
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	1.1964527840425665
COG1-CDG	0.0322581	1.1964527840425665
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.1964527840425665
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.1964527840425665
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.1964527840425665
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	1.1964527840425665
DUBOWITZ SYNDROME	0.03216375	1.1929533429665449
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03216375	1.1929533429665449
CRI-DU-CHAT SYNDROME	0.03216375	1.1929533429665449
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1582059515763998
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03062614	1.1359233949760654
INHERITED CREUTZFELDT-JAKOB DISEASE	0.030293649000000002	1.123591305280172
YOUNG-ONSET PARKINSON DISEASE	0.02975223	1.1035100770031332
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.101979855058529
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0616640313730326
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0616640313730326
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0511810634031071
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.0505130725840384
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0505130725840384
MENKES DISEASE	0.028319219000000003	1.0503597054526197
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.027977684	1.037692173837367
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.030278477175581
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.030278477175581
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.030278477175581
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.030278477175581
CLEFT CHIN	0.027777800000000002	1.030278477175581
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.030278477175581
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.030278477175581
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.030278477175581
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.030278477175581
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.030278477175581
GANGLIOCYTOMA	0.027777800000000002	1.030278477175581
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.030278477175581
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.030278477175581
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.030278477175581
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	1.030278477175581
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.030278477175581
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.030278477175581
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.030278477175581
DWARFISM, LEVI TYPE	0.027777800000000002	1.030278477175581
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.030278477175581
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.030278477175581
NASAL BONES, ABSENCE OF	0.027777800000000002	1.030278477175581
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.030278477175581
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.030278477175581
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.030278477175581
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.030278477175581
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.030278477175581
DIMPLES, FACIAL	0.027777800000000002	1.030278477175581
OROFACIAL CLEFT 3	0.027777800000000002	1.030278477175581
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.030278477175581
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.030278477175581
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.030278477175581
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.030278477175581
MENINGIOMA	0.027777800000000002	1.030278477175581
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0226659039578898
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0225125368264711
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.027495378999999997	1.0198034835546892
N-ACETYLASPARTATE DEFICIENCY; NACED	0.027402773000000002	1.0163687274308306
20Q11.2 MICRODUPLICATION SYNDROME	0.027402773000000002	1.0163687274308306
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0024313085494325
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0024313085494325
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.0024313085494325
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0024313085494325
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0024313085494325
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.026861354	0.996287499153792
7Q11.23 DUPLICATION SYNDROME	0.0263158	0.9760529037453345
KUFOR-RAKEB SYNDROME	0.0263158	0.9760529037453345
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.9760529037453345
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0263158	0.9760529037453345
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.9760529037453345
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.025805929000000002	0.9571417906465294
LISSENCEPHALY 5; LIS5	0.025805929000000002	0.9571417906465294
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.025609454	0.9498545337794243
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.025251104	0.9365633338897329
RHEUMATIC FEVER	0.024900929999999998	0.923575381803301
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9172435261304435
JUVENILE HUNTINGTON DISEASE	0.024246469	0.8993014262542365
GAUCHER DISEASE	0.02404828	0.8919505971348335
ADRENOLEUKODYSTROPHY	0.023862999000000003	0.8850785256774263
PRADER-WILLI SYNDROME	0.023862999000000003	0.8850785256774263
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023392444	0.8676256428419478
SPASTIC PARAPLEGIA TYPE 7	0.02332158	0.8649972974003877
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.022708859	0.8422714782637569
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8350146351929668
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8350146351929668
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8350146351929668
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02247053	0.83343185672473
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.83343185672473
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.022380503000000003	0.8300927556992823
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02197298	0.8149777294605584
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8147800397845095
GABRIELE-DE VRIES SYNDROME; GADEVS	0.021839084	0.8100115274222436
MERCURY POISONING	0.021834949000000003	0.809858160290825
CHROMOSOME 18Q DELETION SYNDROME	0.021834949000000003	0.809858160290825
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.021526313	0.7984108524377347
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.02129353	0.7897769320137862
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.789512628705808
FABRY DISEASE	0.020980758999999998	0.7781762570292774
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.020935434	0.7764951529829534
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.02077868	0.770681147827355
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7692780332973506
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7692780332973506
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7692780332973506
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443214	0.7582387153948303
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.020439339999999997	0.7580950287522387
NIEMANN-PICK DISEASE TYPE B	0.02038988	0.756260557574496
MELAS	0.0202535	0.7512022239873435
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.020092104	0.7452160470726047
19P13.3 MICRODUPLICATION SYNDROME	0.020092104	0.7452160470726047
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.019781293999999998	0.7336881055692839
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.01973794	0.7320801059041028
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.019565429999999998	0.7256817107793067
O'SULLIVAN-MCLEOD SYNDROME	0.019565429999999998	0.7256817107793067
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.019565429999999998	0.7256817107793067
MONOMELIC AMYOTROPHY	0.019565429999999998	0.7256817107793067
MENTAL RETARDATION, X-LINKED 77	0.01954655	0.7249814516641473
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01916308	0.710758551087337
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01916308	0.710758551087337
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.019089194	0.7080181196793568
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7077551516112169
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.018944073000000002	0.7026355824414836
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.018944073000000002	0.7026355824414836
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.018944073000000002	0.7026355824414836
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7026355824414836
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.018944073000000002	0.7026355824414836
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.018944073000000002	0.7026355824414836
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6875205562027595
HYPERPROLINEMIA, TYPE I	0.018429223	0.6835397982550524
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.018402654	0.6825543541644448
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018402654	0.6825543541644448
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.018402654	0.6825543541644448
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.018402654	0.6825543541644448
PEROXISOME BIOGENESIS DISORDER 6B	0.018402654	0.6825543541644448
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018402654	0.6825543541644448
METACHROMATIC LEUKODYSTROPHY	0.018398519000000002	0.6824009870330262
OCULODENTODIGITAL DYSPLASIA; ODDD	0.018398519000000002	0.6824009870330262
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.018398519000000002	0.6824009870330262
MEGALENCEPHALY WITH DYSMYELINATION	0.018398519000000002	0.6824009870330262
MYOCLONIC-ATONIC EPILEPSY	0.01836183	0.6810401921878946
PEDIATRIC-ONSET GRAVES DISEASE	0.018233294	0.6762727925254937
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	0.6623197587559874
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0178571	0.6623197587559874
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0178571	0.6623197587559874
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0178571	0.6623197587559874
NEONATAL LUPUS ERYTHEMATOSUS	0.0178571	0.6623197587559874
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6623197587559874
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0178571	0.6623197587559874
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	0.6623197587559874
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0178571	0.6623197587559874
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	0.6623197587559874
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.0178571	0.6623197587559874
ATAXIA-PANCYTOPENIA SYNDROME	0.0178571	0.6623197587559874
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.017680584	0.655772781109193
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.017504334	0.6492356694012034
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017504334	0.6492356694012034
CARDIAC ARRHYTHMIA	0.0172414	0.6394834485227434
RHEUMATOID ARTHRITIS	0.0172414	0.6394834485227434
CERVICAL RIB	0.0172414	0.6394834485227434
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6394834485227434
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6394834485227434
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6394834485227434
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6394834485227434
269800 SENILE PLAQUE FORMATION	0.0172414	0.6394834485227434
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6394834485227434
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6394834485227434
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6394834485227434
MYOPATHY, CONGENITAL	0.0172414	0.6394834485227434
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6394834485227434
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6394834485227434
ERYTHERMALGIA, PRIMARY	0.0172414	0.6394834485227434
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6394834485227434
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6394834485227434
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6394834485227434
DIASTEMATOMYELIA	0.0172414	0.6394834485227434
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6394834485227434
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6394834485227434
MOSAIC TRISOMY 15	0.0172414	0.6394834485227434
PALMOMENTAL REFLEX	0.0172414	0.6394834485227434
MOTION SICKNESS	0.0172414	0.6394834485227434
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6394834485227434
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6394834485227434
SICKLE CELL ANEMIA	0.0172414	0.6394834485227434
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6394834485227434
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6394834485227434
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6394834485227434
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6394834485227434
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6394834485227434
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6394834485227434
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6394834485227434
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6394834485227434
TRANSSEXUALITY	0.0172414	0.6394834485227434
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6394834485227434
THUMBS, CONGENITAL CLASPED	0.0172414	0.6394834485227434
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6394834485227434
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6394834485227434
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6394834485227434
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6394834485227434
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6394834485227434
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6394834485227434
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6394834485227434
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6394834485227434
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6394834485227434
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6394834485227434
ALCOHOL DEPENDENCE	0.0172414	0.6394834485227434
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6394834485227434
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6394834485227434
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6394834485227434
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6394834485227434
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6394834485227434
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.017215973	0.638540361207004
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.017215973	0.638540361207004
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.017215973	0.638540361207004
SNEDDON SYNDROME	0.017060119	0.6327597370473613
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.016897743	0.6267372119370264
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016891613	0.6265098502645726
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6248575280547615
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6248575280547615
1Q41Q42 MICRODELETION SYNDROME	0.016720759	0.6201728761723351
WITTEVEEN-KOLK SYNDROME	0.016709743000000003	0.6197642927818375
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.016674553999999998	0.6184591329299653
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.016674553999999998	0.6184591329299653
HEREDITARY HYPEREKPLEXIA	0.016670419	0.6183057657985467
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.016350194	0.6064286219875339
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.016350194	0.6064286219875339
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.016350194	0.6064286219875339
GABRIELE-DE VRIES SYNDROME	0.01630832	0.6048755155157022
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.604622932646304
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.604622932646304
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.604622932646304
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.604622932646304
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.016128999999999998	0.598224537521508
SPINOCEREBELLAR ATAXIA 2; SCA2	0.016128999999999998	0.598224537521508
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.016128999999999998	0.598224537521508
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.016128999999999998	0.598224537521508
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.016128999999999998	0.598224537521508
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.016128999999999998	0.598224537521508
NEUTRAL LIPID STORAGE MYOPATHY	0.016128999999999998	0.598224537521508
SPINOCEREBELLAR ATAXIA 34; SCA34	0.016128999999999998	0.598224537521508
MULTIFOCAL MOTOR NEUROPATHY	0.016128999999999998	0.598224537521508
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.016128999999999998	0.598224537521508
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.016128999999999998	0.598224537521508
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.016128999999999998	0.598224537521508
SPINOCEREBELLAR ATAXIA TYPE 2	0.016128999999999998	0.598224537521508
SPINOCEREBELLAR ATAXIA TYPE 1	0.016128999999999998	0.598224537521508
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.016128999999999998	0.598224537521508
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.016128999999999998	0.598224537521508
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.016128999999999998	0.598224537521508
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.016128999999999998	0.598224537521508
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.016128999999999998	0.598224537521508
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.016128999999999998	0.598224537521508
SANDHOFF DISEASE	0.016128999999999998	0.598224537521508
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.016128999999999998	0.598224537521508
AMYOTROPHY, MONOMELIC	0.016128999999999998	0.598224537521508
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.016128999999999998	0.598224537521508
AMYOTROPHIC LATERAL SCLEROSIS 1	0.016128999999999998	0.598224537521508
POSTPOLIOMYELITIS SYNDROME	0.016128999999999998	0.598224537521508
HYPERKALEMIC PERIODIC PARALYSIS	0.016128999999999998	0.598224537521508
MACHADO-JOSEPH DISEASE; MJD	0.016128999999999998	0.598224537521508
ATAXIA WITH FASCICULATIONS	0.016128999999999998	0.598224537521508
YUNIS-VARON SYNDROME	0.015810770000000002	0.5864213882515303
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01580464	0.5861940265790766
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.5861940265790766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01580464	0.5861940265790766
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5738176143385532
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5738176143385532
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.5738176143385532
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5738176143385532
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5738176143385532
LANDAU-KLEFFNER SYNDROME	0.015323383	0.5683442066116894
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.015165434000000002	0.5624858789114611
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.014954813	0.5546739469679234
FG SYNDROME TYPE 1	0.014954813	0.5546739469679234
JACOBSEN SYNDROME	0.014954813	0.5546739469679234
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01493073	0.5537807086061445
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5535830189300958
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5535830189300958
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5535830189300958
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.014792729000000001	0.5486622521362763
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.014656572999999999	0.5436122267081172
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01444966	0.5359378244679169
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01444966	0.5359378244679169
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.5359378244679169
AMISH LETHAL MICROCEPHALY	0.01444966	0.5359378244679169
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01444966	0.5359378244679169
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01444966	0.5359378244679169
CORNELIA DE LANGE SYNDROME	0.014409259	0.534439351559466
ADENYLOSUCCINASE DEFICIENCY	0.014342333	0.5319570665202098
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5283156078513942
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5283156078513942
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5283156078513942
AYMÃ‰-GRIPP SYNDROME	0.014244153999999998	0.5283156078513942
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5283156078513942
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.014244153999999998	0.5283156078513942
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014244153999999998	0.5283156078513942
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.014136138999999999	0.5243093319867785
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.013958862999999998	0.5177341659433994
21Q22.11Q22.12 MICRODELETION SYNDROME	0.013796779	0.5117224711117524
SMITH-FINEMAN-MYERS SYNDROME	0.013796779	0.5117224711117524
PITT-HOPKINS-LIKE SYNDROME	0.013796779	0.5117224711117524
CHOREOACANTHOCYTOSIS	0.013752669000000002	0.5100864314099685
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5080810124429369
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5080810124429369
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5080810124429369
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5080810124429369
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5080810124429369
MENKES DISEASE	0.013623689000000001	0.5053025637895627
METACHROMATIC LEUKODYSTROPHY	0.013623689000000001	0.5053025637895627
CARNOSINASE DEFICIENCY	0.013569600000000001	0.5032964030226211
8P INVERTED DUPLICATION/DELETION SYNDROME	0.013413309	0.4974995705349421
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01325536	0.49164124283471367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.013241244	0.49111768045814636
WILLIAMS SYNDROME	0.01321125	0.4900052031329297
NEUROFERRITINOPATHY	0.01308227	0.48522133551252394
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.012926763	0.479453581581322
HALLERMANN-STREIFF SYNDROME; HSS	0.012890200000000001	0.4780974600756242
TONNE-KALSCHEUER SYNDROME; TOKAS	0.012753914000000002	0.47304261294804933
NEONATAL ADRENOLEUKODYSTROPHY	0.012259169	0.45469252312127273
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.012259169	0.45469252312127273
COG8-CDG	0.012259169	0.45469252312127273
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.012208360000000001	0.45280801753959193
SPINOCEREBELLAR ATAXIA TYPE 38	0.012208360000000001	0.45280801753959193
CORTICOBASAL SYNDROME	0.012208360000000001	0.45280801753959193
SPINOCEREBELLAR ATAXIA TYPE 21	0.012208360000000001	0.45280801753959193
RING CHROMOSOME 14 SYNDROME	0.012039854	0.4465581307568032
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012039854	0.4465581307568032
WRINKLY SKIN SYNDROME	0.012039854	0.4465581307568032
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.012039854	0.4465581307568032
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.4465581307568032
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.4465581307568032
PERLMAN SYNDROME	0.012039854	0.4465581307568032
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.4465581307568032
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.4465581307568032
PEHO-LIKE SYNDROME; PEHOL	0.012039854	0.4465581307568032
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012039854	0.4465581307568032
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.4465581307568032
FUMARASE DEFICIENCY; FMRD	0.012039854	0.4465581307568032
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4465581307568032
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.4465581307568032
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.4465581307568032
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.4465581307568032
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.4465581307568032
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.4465581307568032
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.012039854	0.4465581307568032
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4263235353483458
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4263235353483458
DESMOSTEROLOSIS	0.011494299999999999	0.4263235353483458
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4263235353483458
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4263235353483458
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4263235353483458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.011385259	0.42227920514834066
4Q21 MICRODELETION SYNDROME	0.011385259	0.42227920514834066
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.011385259	0.42227920514834066
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.01131243	0.4195779778656106
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.011024234	0.40888878952066987
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.011020099	0.40873542238925126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.010861793000000002	0.40286385356062704
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.010699709000000002	0.39685215872897994
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01047868	0.3886541941122125
MENTAL RETARDATION, X-LINKED 104; MRX104	0.010371353	0.3846734361645052
LYNCH SYNDROME	0.010316239000000001	0.3826292581521697
FAMILIAL COLORECTAL CANCER TYPE X	0.010316239000000001	0.3826292581521697
NORRIE DISEASE	0.010316239000000001	0.3826292581521697
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.01015829	0.3767709304519412
TRISOMY X	0.009987883	0.3704505355876949
49,XXXXY SYNDROME	0.009987883	0.3704505355876949
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.009987883	0.3704505355876949
CLASSIC PHENYLKETONURIA	0.009987883	0.3704505355876949
48,XXXY SYNDROME	0.009987883	0.3704505355876949
48,XXYY SYNDROME	0.009987883	0.3704505355876949
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.009987883	0.3704505355876949
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.009987883	0.3704505355876949
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009858903	0.36566666796728925
INFANTILE REFSUM DISEASE	0.009858903	0.36566666796728925
SOTOS SYNDROME	0.009858903	0.36566666796728925
MYHRE SYNDROME	0.009858903	0.36566666796728925
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009858903	0.36566666796728925
ARGININEMIA	0.009858903	0.36566666796728925
WEAVER SYNDROME	0.009858903	0.36566666796728925
HEREDITARY FOLATE MALABSORPTION	0.009858903	0.36566666796728925
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009858903	0.36566666796728925
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009858903	0.36566666796728925
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.009858903	0.36566666796728925
RAYNAUD-CLAES SYNDROME; MRXSRC	0.009858903	0.36566666796728925
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.009858903	0.36566666796728925
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.009858903	0.36566666796728925
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009858903	0.36566666796728925
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009858903	0.36566666796728925
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.009829934	0.36459220788746655
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.009825799	0.3644388407560479
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.009825799	0.3644388407560479
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36366050720034765
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.36366050720034765
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36366050720034765
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.36366050720034765
KRABBE DISEASE	0.009804814	0.36366050720034765
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36366050720034765
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36366050720034765
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.36366050720034765
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36366050720034765
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36366050720034765
BIOTINIDASE DEFICIENCY	0.009804814	0.36366050720034765
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.36366050720034765
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36366050720034765
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.363507140068929
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.363507140068929
EMANUEL SYNDROME	0.009490333	0.3519964083235232
INFANTILE SIALIC ACID STORAGE DISEASE	0.009490333	0.3519964083235232
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.3519964083235232
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.009490333	0.3519964083235232
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.009490333	0.3519964083235232
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.3519964083235232
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009490333	0.3519964083235232
CONGENITAL TOXOPLASMOSIS	0.009490333	0.3519964083235232
KAGAMI-OGATA SYNDROME	0.009490333	0.3519964083235232
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	0.3519964083235232
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.3519964083235232
KAGAMI-OGATA SYNDROME	0.009490333	0.3519964083235232
GALLOWAY-MOWAT SYNDROME	0.009490333	0.3519964083235232
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.3519964083235232
FETAL ALCOHOL SYNDROME	0.009317484000000001	0.3455854396902506
20Q11.2 MICRODELETION SYNDROME	0.009317484000000001	0.3455854396902506
MONOSOMY 18P	0.009317484000000001	0.3455854396902506
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.3455854396902506
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.3455854396902506
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.009313349	0.3454320725588319
SCLERODERMA	0.009313349	0.3454320725588319
FAMILIAL DYSAUTONOMIA	0.009313349	0.3454320725588319
PINEOBLASTOMA	0.009313349	0.3454320725588319
CORNELIA DE LANGE SYNDROME 1	0.009313349	0.3454320725588319
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.3454320725588319
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.009313349	0.3454320725588319
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009313349	0.3454320725588319
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.009313349	0.3454320725588319
NEUROCUTANEOUS MELANOCYTOSIS	0.009313349	0.3454320725588319
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.3454320725588319
5Q35 MICRODUPLICATION SYNDROME	0.009313349	0.3454320725588319
CRYPTOCOCCOSIS	0.009313349	0.3454320725588319
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.009313349	0.3454320725588319
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.009313349	0.3454320725588319
L-2-HYDROXYGLUTARIC ACIDURIA	0.009313349	0.3454320725588319
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.3454320725588319
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.3454320725588319
9Q33.3Q34.11 MICRODELETION SYNDROME	0.009313349	0.3454320725588319
ANGELMAN SYNDROME	0.009313349	0.3454320725588319
2Q33.1 DELETION SYNDROME	0.009313349	0.3454320725588319
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.009313349	0.3454320725588319
GAUCHER DISEASE TYPE 2	0.00925926	0.3434259117918903
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3434259117918903
GLYCINE ENCEPHALOPATHY	0.00925926	0.3434259117918903
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3434259117918903
CARNOSINEMIA	0.00925926	0.3434259117918903
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3434259117918903
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3434259117918903
GAUCHER DISEASE TYPE 3	0.00925926	0.3434259117918903
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3434259117918903
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3434259117918903
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3434259117918903
PAINE SYNDROME	0.00925926	0.3434259117918903
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3434259117918903
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3434259117918903
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3434259117918903
HYDROXYLYSINURIA	0.00925926	0.3434259117918903
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3434259117918903
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.008948914	0.3319151800464845
TYSHCHENKO SYNDROME	0.008948914	0.3319151800464845
ROBERTS SYNDROME	0.008948914	0.3319151800464845
COSTELLO SYNDROME; CSTLO	0.008948914	0.3319151800464845
ROIFMAN SYNDROME; RFMN	0.008948914	0.3319151800464845
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.3319151800464845
CINCA SYNDROME	0.008948914	0.3319151800464845
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.3319151800464845
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.3319151800464845
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	0.3319151800464845
CARDIOFACIOCUTANEOUS SYNDROME	0.008948914	0.3319151800464845
VASCULAR EHLERS-DANLOS SYNDROME	0.008948914	0.3319151800464845
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.3319151800464845
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.008944779	0.33176181291506585
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.33176181291506585
ADAMS-OLIVER SYNDROME	0.008944779	0.33176181291506585
MICROFORM HOLOPROSENCEPHALY	0.008944779	0.33176181291506585
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.33176181291506585
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.33176181291506585
MOHR-TRANEBJAERG SYNDROME	0.00890091	0.3301347119021989
NIEMANN-PICK DISEASE TYPE C	0.008833743000000002	0.3276434881740256
CHÃ‰DIAK-HIGASHI SYNDROME	0.008833743	0.3276434881740256
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.008833743	0.3276434881740256
AICARDI-GOUTIÃˆRES SYNDROME	0.008833743	0.3276434881740256
NANCE-HORAN SYNDROME	0.00877193	0.3253508442817932
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.3253508442817932
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.3253508442817932
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.3253508442817932
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.3253508442817932
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.3253508442817932
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.3253508442817932
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.3253508442817932
CAFFEY DISEASE	0.00877193	0.3253508442817932
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.3253508442817932
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.3253508442817932
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.3253508442817932
MILROY DISEASE	0.00877193	0.3253508442817932
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.3253508442817932
KEIPERT SYNDROME	0.00877193	0.3253508442817932
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.3253508442817932
BREATH-HOLDING SPELLS	0.00877193	0.3253508442817932
LOCKED-IN SYNDROME	0.00877193	0.3253508442817932
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.3253508442817932
HISTIDINEMIA	0.00877193	0.3253508442817932
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.3253508442817932
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00877193	0.3253508442817932
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.3253508442817932
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.3253508442817932
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.3253508442817932
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.3253508442817932
PIERPONT SYNDROME	0.008494383	0.31505662729899925
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.008494383	0.31505662729899925
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.31505662729899925
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.31505662729899925
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.31505662729899925
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.31505662729899925
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.31505662729899925
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.008494383	0.31505662729899925
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.3116805846380271
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.3116805846380271
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.3116805846380271
FATCO SYNDROME	0.00840336	0.3116805846380271
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.3116805846380271
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3116805846380271
TEMPLE SYNDROME	0.00840336	0.3116805846380271
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.3116805846380271
HEC SYNDROME	0.00840336	0.3116805846380271
EBSTEIN MALFORMATION	0.00840336	0.3116805846380271
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.3116805846380271
RENAL TUBULAR DYSGENESIS	0.00840336	0.3116805846380271
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.3116805846380271
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.3116805846380271
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3116805846380271
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.3116805846380271
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.3116805846380271
PEMPHIGOID GESTATIONIS	0.00840336	0.3116805846380271
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.3116805846380271
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3116805846380271
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.3116805846380271
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.3116805846380271
NEMALINE MYOPATHY 10	0.00840336	0.3116805846380271
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.3116805846380271
RETINOPATHY OF PREMATURITY	0.00840336	0.3116805846380271
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.3116805846380271
VACTERL/VATER ASSOCIATION	0.00840336	0.3116805846380271
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3116805846380271
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3116805846380271
SCHISIS ASSOCIATION	0.00840336	0.3116805846380271
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3116805846380271
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.3116805846380271
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.3116805846380271
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.3116805846380271
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.3116805846380271
TEMPLE SYNDROME	0.00840336	0.3116805846380271
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.3116805846380271
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.3116805846380271
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.3116805846380271
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.3116805846380271
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3116805846380271
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3116805846380271
GMS SYNDROME	0.00840336	0.3116805846380271
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.3116805846380271
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.3116805846380271
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.3116805846380271
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.3116805846380271
DISTAL MONOSOMY 17Q	0.00840336	0.3116805846380271
SILVER-RUSSELL SYNDROME	0.00840336	0.3116805846380271
HYDROLETHALUS	0.00840336	0.3116805846380271
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.3116805846380271
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.3116805846380271
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3116805846380271
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	0.3116805846380271
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.3116805846380271
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.3116805846380271
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.3116805846380271
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.3116805846380271
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3116805846380271
OMPHALOCELE	0.00840336	0.3116805846380271
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3116805846380271
HYPERMANGANESEMIA WITH DYSTONIA 2	0.008292324	0.3075622598969869
AICARDI-GOUTIERES SYNDROME 6	0.008292324	0.3075622598969869
ALEXANDER DISEASE	0.008288189000000001	0.30740889276556826
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.008288189000000001	0.30740889276556826
CEREBROTENDINOUS XANTHOMATOSIS	0.008288189000000001	0.30740889276556826
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.008288189000000001	0.30740889276556826
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.29497539902196057
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.29497539902196057
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.007948829	0.2948220318905419
FRYNS SYNDROME	0.007948829	0.2948220318905419
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.007948829	0.2948220318905419
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.2948220318905419
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.2948220318905419
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.007948829	0.2948220318905419
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.2948220318905419
ADRENOMYODYSTROPHY	0.007948829	0.2948220318905419
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.2948220318905419
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.2948220318905419
CROME SYNDROME	0.007948829	0.2948220318905419
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.2948220318905419
BOWEN-CONRADI SYNDROME	0.007948829	0.2948220318905419
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.007948829	0.2948220318905419
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.007948829	0.2948220318905419
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.007948829	0.2948220318905419
SECKEL SYNDROME 7; SCKL7	0.007948829	0.2948220318905419
2Q24 MICRODELETION SYNDROME	0.007948829	0.2948220318905419
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.007948829	0.2948220318905419
MEHMO SYNDROME	0.007948829	0.2948220318905419
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.2948220318905419
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.007948829	0.2948220318905419
COFFIN-LOWRY SYNDROME	0.007948829	0.2948220318905419
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.2948220318905419
TRISOMY 13	0.007948829	0.2948220318905419
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.007948829	0.2948220318905419
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.2948220318905419
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.007948829	0.2948220318905419
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.2948220318905419
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007948829	0.2948220318905419
CONO-SPONDYLAR DYSPLASIA	0.007948829	0.2948220318905419
TEMPLE-BARAITSER SYNDROME	0.007948829	0.2948220318905419
QAZI-MARKOUIZOS SYNDROME	0.007948829	0.2948220318905419
INTELLECTUAL DISABILITY, WOLFF TYPE	0.007948829	0.2948220318905419
DPM1-CDG	0.007948829	0.2948220318905419
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.007948829	0.2948220318905419
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.007948829	0.2948220318905419
COFS SYNDROME	0.007948829	0.2948220318905419
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.2948220318905419
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.2948220318905419
LOWRY-MACLEAN SYNDROME	0.007948829	0.2948220318905419
KEPPEN-LUBINSKY SYNDROME	0.007948829	0.2948220318905419
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.007948829	0.2948220318905419
HALL-RIGGS SYNDROME	0.007948829	0.2948220318905419
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.2948220318905419
HENNEKAM-BEEMER SYNDROME	0.007948829	0.2948220318905419
ATAXIA WITH VITAMIN E DEFICIENCY	0.00774677	0.2873276644885295
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28143161626287116
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28143161626287116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.28143161626287116
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.007587804	0.28143161626287116
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28143161626287116
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28143161626287116
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.28143161626287116
1Q44 MICRODELETION SYNDROME	0.007587804	0.28143161626287116
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28143161626287116
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.28143161626287116
PELGER-HUET ANOMALY; PHA	0.007587804	0.28143161626287116
W SYNDROME	0.007587804	0.28143161626287116
X SMALL RINGS	0.007587804	0.28143161626287116
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.28143161626287116
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28127824913145244
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2747408036135032
RING CHROMOSOME 7 SYNDROME	0.00740741	0.2747408036135032
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.2747408036135032
MONOSOMY 5P	0.00740741	0.2747408036135032
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.2747408036135032
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2747408036135032
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.2747408036135032
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.2747408036135032
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.2747408036135032
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.2747408036135032
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2747408036135032
KID SYNDROME	0.00740741	0.2747408036135032
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00740741	0.2747408036135032
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2747408036135032
TRISOMY XQ28	0.00740741	0.2747408036135032
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.2747408036135032
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00740741	0.2747408036135032
DISTAL MONOSOMY 10P	0.00740741	0.2747408036135032
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.2747408036135032
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26119702085441376
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26119702085441376
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26119702085441376
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26119702085441376
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26119702085441376
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26119702085441376
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26119702085441376
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26119702085441376
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26119702085441376
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26119702085441376
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26119702085441376
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26119702085441376
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26119702085441376
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26119702085441376
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26119702085441376
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26119702085441376
OLIVER SYNDROME	0.00704225	0.26119702085441376
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26119702085441376
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26119702085441376
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.006934923000000001	0.2572162629067065
XQ25 DUPLICATION SYNDROME	0.006934923000000001	0.2572162629067065
MEND SYNDROME; MEND	0.006934923000000001	0.2572162629067065
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.006934923000000001	0.2572162629067065
GLASS SYNDROME	0.006934923000000001	0.2572162629067065
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.006934923000000001	0.2572162629067065
DISTAL TRISOMY 17Q	0.006934923000000001	0.2572162629067065
MENTAL RETARDATION, X-LINKED 72	0.006934923000000001	0.2572162629067065
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.006934923000000001	0.2572162629067065
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.006934923000000001	0.2572162629067065
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.006934923000000001	0.2572162629067065
MEND SYNDROME	0.006934923000000001	0.2572162629067065
MONOSOMY 9Q22.3	0.006934923000000001	0.2572162629067065
8Q24.3 MICRODELETION SYNDROME	0.006934923000000001	0.2572162629067065
ANGELMAN SYNDROME	0.006934923000000001	0.2572162629067065
POTOCKI-LUPSKI SYNDROME	0.006934923000000001	0.2572162629067065
CHROMOSOME 2Q37 DELETION SYNDROME	0.006934923000000001	0.2572162629067065
OCULOECTODERMAL SYNDROME; OES	0.006934923000000001	0.2572162629067065
CK SYNDROME	0.006934923000000001	0.2572162629067065
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.006934923000000001	0.2572162629067065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.006934923000000001	0.2572162629067065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.006934923000000001	0.2572162629067065
19P13.12 MICRODELETION SYNDROME	0.006934923000000001	0.2572162629067065
MONOSOMY 22Q13.3	0.006934923000000001	0.2572162629067065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.006934923000000001	0.2572162629067065
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.006934923000000001	0.2572162629067065
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.006934923000000001	0.2572162629067065
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.006934923000000001	0.2572162629067065
MENTAL RETARDATION, X-LINKED 101; MRX101	0.006934923000000001	0.2572162629067065
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.006934923000000001	0.2572162629067065
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.006934923000000001	0.2572162629067065
MATERNAL PHENYLKETONURIA	0.006934923000000001	0.2572162629067065
XQ25 MICRODUPLICATION SYNDROME	0.006934923000000001	0.2572162629067065
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.006934923000000001	0.2572162629067065
HELSMOORTEL-VAN DER AA SYNDROME	0.006934923000000001	0.2572162629067065
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.006934923000000001	0.2572162629067065
TETRASOMY 9P	0.006934923000000001	0.2572162629067065
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.006934923000000001	0.2572162629067065
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0065514530000000005	0.24299336232989624
22Q11.2 DELETION SYNDROME	0.0065514530000000005	0.24299336232989624
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.0065514530000000005	0.24299336232989624
15Q11Q13 MICRODUPLICATION SYNDROME	0.0065514530000000005	0.24299336232989624
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.0065514530000000005	0.24299336232989624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0065514530000000005	0.24299336232989624
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.0065514530000000005	0.24299336232989624
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.0065514530000000005	0.24299336232989624
SMITH-LEMLI-OPITZ SYNDROME	0.0065514530000000005	0.24299336232989624
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.0065514530000000005	0.24299336232989624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.006551453	0.24299336232989618
15Q24 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.006551453	0.24299336232989618
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
RUBINSTEIN-TAYBI SYNDROME	0.006551453	0.24299336232989618
8P23.1 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
SIALURIA	0.006551453	0.24299336232989618
11Q22.2Q22.3 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.006551453	0.24299336232989618
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.006551453	0.24299336232989618
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.006551453	0.24299336232989618
SMITH-MAGENIS SYNDROME	0.006551453	0.24299336232989618
DESANTO-SHINAWI SYNDROME	0.006551453	0.24299336232989618
1Q21.1 MICRODUPLICATION SYNDROME	0.006551453	0.24299336232989618
DISTAL MONOSOMY 15Q	0.006551453	0.24299336232989618
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.006551453	0.24299336232989618
1Q21.1 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.006551453	0.24299336232989618
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.006551453	0.24299336232989618
MUENKE SYNDROME	0.006551453	0.24299336232989618
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.006551453	0.24299336232989618
16P13.2 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.006551453	0.24299336232989618
SHUKLA-VERNON SYNDROME; SHUVER	0.006551453	0.24299336232989618
2Q37 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
19P13.13 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
DIGEORGE SYNDROME; DGS	0.006551453	0.24299336232989618
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.006551453	0.24299336232989618
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.006551453	0.24299336232989618
PRADER-WILLI SYNDROME; PWS	0.006551453	0.24299336232989618
10Q22.3Q23.3 MICRODELETION SYNDROME	0.006551453	0.24299336232989618
22Q11.2 MICRODUPLICATION SYNDROME	0.006551453	0.24299336232989618
INCONTINENTIA PIGMENTI	0.006551453	0.24299336232989618
ALAZAMI-YUAN SYNDROME	0.006393504	0.23713503462966778
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.006393504	0.23713503462966778
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.006393504	0.23713503462966778
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.006393504	0.23713503462966778
16P11.2P12.2 MICRODELETION SYNDROME	0.006393504	0.23713503462966778
JOUBERT SYNDROME 1	0.006393504	0.23713503462966778
OPTIC ATROPHY 11; OPA11	0.006393504	0.23713503462966778
COFFIN-SIRIS SYNDROME 7; CSS7	0.006393504	0.23713503462966778
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006393504	0.23713503462966778
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.006393504	0.23713503462966778
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.006393504	0.23713503462966778
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.006393504	0.23713503462966778
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.006393504	0.23713503462966778
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.006393504	0.23713503462966778
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.006393504	0.23713503462966778
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.006393504	0.23713503462966778
MENTAL RETARDATION, X-LINKED 107; MRX107	0.006393504	0.23713503462966778
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.006389369000000001	0.23698166749824917
2Q23.1 MICRODELETION SYNDROME	0.006389369000000001	0.23698166749824917
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.006389369000000001	0.23698166749824917
FRAGILE X MENTAL RETARDATION SYNDROME	0.006389369000000001	0.23698166749824917
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.006389369000000001	0.23698166749824917
MENTAL RETARDATION, X-LINKED 21	0.006389369000000001	0.23698166749824917
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.006389369000000001	0.23698166749824917
DUPLICATION/INVERSION 15Q11	0.006389369000000001	0.23698166749824917
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.006389369000000001	0.23698166749824917
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.006389369000000001	0.23698166749824917
MENTAL RETARDATION, X-LINKED 102	0.006389369000000001	0.23698166749824917
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.006389369000000001	0.23698166749824917
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.006389369000000001	0.23698166749824917
SECKEL SYNDROME 1; SCKL1	0.006389369000000001	0.23698166749824917
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.006389369000000001	0.23698166749824917
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.006389369000000001	0.23698166749824917
GLYCINE ENCEPHALOPATHY; GCE	0.006389369000000001	0.23698166749824917
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.006389369000000001	0.23698166749824917
COFFIN-SIRIS SYNDROME 8; CSS8	0.006389369000000001	0.23698166749824917
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.006389369000000001	0.23698166749824917
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.006389369000000001	0.23698166749824917
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.006389369000000001	0.23698166749824917
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.006389369000000001	0.23698166749824917
TRANSKETOLASE DEFICIENCY	0.006010034	0.2229121340528575
17P11.2 MICRODUPLICATION SYNDROME	0.006010034	0.2229121340528575
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.006010034	0.2229121340528575
COFFIN-SIRIS SYNDROME 6; CSS6	0.006010034	0.2229121340528575
2Q32Q33 MICRODELETION SYNDROME	0.006010034	0.2229121340528575
MARDEN-WALKER SYNDROME	0.006010034	0.2229121340528575
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006010034	0.2229121340528575
CHROMOSOME 15Q25 DELETION SYNDROME	0.006010034	0.2229121340528575
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.006010034	0.2229121340528575
OBESITY DUE TO SIM1 DEFICIENCY	0.006010034	0.2229121340528575
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.006010034	0.2229121340528575
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.006010034	0.2229121340528575
17Q21.31 MICRODUPLICATION SYNDROME	0.006010034	0.2229121340528575
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.006010034	0.2229121340528575
2P15P16.1 MICRODELETION SYNDROME	0.006010034	0.2229121340528575
TURNPENNY-FRY SYNDROME; TPFS	0.006010034	0.2229121340528575
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.006010034	0.2229121340528575
16P13.11 MICRODUPLICATION SYNDROME	0.006010034	0.2229121340528575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.006010034	0.2229121340528575
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.006010034	0.2229121340528575
CHARGE SYNDROME	0.006010034	0.2229121340528575
3Q29 MICRODELETION SYNDROME	0.006010034	0.2229121340528575
8Q12 MICRODUPLICATION SYNDROME	0.006010034	0.2229121340528575
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.006010034	0.2229121340528575
AARSKOG-SCOTT SYNDROME	0.006010034	0.2229121340528575
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.006010034	0.2229121340528575
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.006010034	0.2229121340528575
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.006005899	0.2227587669214389
47,XYY SYNDROME	0.006005899	0.2227587669214389
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.006005899	0.2227587669214389
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.006005899	0.2227587669214389
DUBOWITZ SYNDROME	0.006005899	0.2227587669214389
CYCLIC VOMITING SYNDROME	0.006005899	0.2227587669214389
FRAGILE X SYNDROME	0.006005899	0.2227587669214389
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.006005899	0.2227587669214389
NEUROFIBROMATOSIS TYPE 1	0.006005899	0.2227587669214389
OCULOCEREBRORENAL SYNDROME OF LOWE	0.006005899	0.2227587669214389
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.006005899	0.2227587669214389
STURGE-WEBER SYNDROME	0.006005899	0.2227587669214389
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.006005899	0.2227587669214389
RABIES	0.006005899	0.2227587669214389
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.006005899	0.2227587669214389
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.006005899	0.2227587669214389
PHENYLKETONURIA	0.006005899	0.2227587669214389
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00584795	0.21690043922121044
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00584795	0.21690043922121044
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00584795	0.21690043922121044
FRAXE INTELLECTUAL DISABILITY	0.00584795	0.21690043922121044
SCHIZOPHRENIA 15; SCZD15	0.00584795	0.21690043922121044
8P23.1 DELETION SYNDROME	0.00584795	0.21690043922121044
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00584795	0.21690043922121044
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00584795	0.21690043922121044
SMITH-MAGENIS SYNDROME	0.00584795	0.21690043922121044
13Q12.3 MICRODELETION SYNDROME	0.00584795	0.21690043922121044
SOTOS SYNDROME 3	0.00584795	0.21690043922121044
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00584795	0.21690043922121044
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00584795	0.21690043922121044
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00584795	0.21690043922121044
NIJMEGEN BREAKAGE SYNDROME	0.00584795	0.21690043922121044
IMMUNODEFICIENCY 61; IMD61	0.00546448	0.20267753864440016
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00546448	0.20267753864440016
MARFAN SYNDROME	0.00546448	0.20267753864440016
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00546448	0.20267753864440016
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00546448	0.20267753864440016
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00546448	0.20267753864440016
NIJMEGEN BREAKAGE SYNDROME	0.00546448	0.20267753864440016
RECESSIVE X-LINKED ICHTHYOSIS	0.00546448	0.20267753864440016
MONOSOMY X	0.00546448	0.20267753864440016
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00546448	0.20267753864440016
MICROTIA	0.00546448	0.20267753864440016
X-LINKED ADRENOLEUKODYSTROPHY	0.00546448	0.20267753864440016
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00546448	0.20267753864440016
TRISOMY 18P	0.00546448	0.20267753864440016
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00546448	0.20267753864440016
EARLY-ONSET SCHIZOPHRENIA	0.00546448	0.20267753864440016
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.20267753864440016
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.00546448	0.20267753864440016
SCHWARTZ-JAMPEL SYNDROME	0.00546448	0.20267753864440016
SPINOCEREBELLAR ATAXIA 14	0.00546448	0.20267753864440016
16P12.1P12.3 TRIPLICATION SYNDROME	0.00546448	0.20267753864440016
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00546448	0.20267753864440016
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00546448	0.20267753864440016
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.00546448	0.20267753864440016
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.20267753864440016
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00546448	0.20267753864440016
LEGIUS SYNDROME	0.00546448	0.20267753864440016
MOSAIC MONOSOMY X	0.00546448	0.20267753864440016
TURNER SYNDROME	0.00546448	0.20267753864440016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.005397313000000001	0.2001863149162269
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005397313000000001	0.2001863149162269
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005397313000000001	0.2001863149162269
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.005397313000000001	0.2001863149162269
SCHINDLER DISEASE, TYPE I	0.005397313000000001	0.2001863149162269
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.005397313000000001	0.2001863149162269
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.005397313000000001	0.2001863149162269
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005397313000000001	0.2001863149162269
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.005397313000000001	0.2001863149162269
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.005397313000000001	0.2001863149162269
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.005397313000000001	0.2001863149162269
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.005397313000000001	0.2001863149162269
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.005397313000000001	0.2001863149162269
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005397313000000001	0.2001863149162269
CANAVAN DISEASE	0.005397313000000001	0.2001863149162269
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005397313000000001	0.2001863149162269
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.005397313000000001	0.2001863149162269
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005397313000000001	0.2001863149162269
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.005397313000000001	0.2001863149162269
OPTIC PATHWAY GLIOMA	0.005397313	0.20018631491622685
KLEEFSTRA SYNDROME	0.005397313	0.20018631491622685
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.005397313	0.20018631491622685
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005397313	0.20018631491622685
MULTIPLE SULFATASE DEFICIENCY	0.005397313	0.20018631491622685
ZTTK SYNDROME; ZTTKS	0.005397313	0.20018631491622685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.005397313	0.20018631491622685
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005397313	0.20018631491622685
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005397313	0.20018631491622685
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.005397313	0.20018631491622685
TAY-SACHS DISEASE	0.005397313	0.20018631491622685
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.005397313	0.20018631491622685
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.005397313	0.20018631491622685
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.005397313	0.20018631491622685
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.005397313	0.20018631491622685
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.005397313	0.20018631491622685
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.005397313	0.20018631491622685
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.005397313	0.20018631491622685
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005397313	0.20018631491622685
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.005397313	0.20018631491622685
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.005397313	0.20018631491622685
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005397313	0.20018631491622685
AICARDI-GOUTIERES SYNDROME 7	0.005397313	0.20018631491622685
RING CHROMOSOME 22 SYNDROME	0.005397313	0.20018631491622685
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.005397313	0.20018631491622685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005397313	0.20018631491622685
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005397313	0.20018631491622685
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.005397313	0.20018631491622685
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.18010508663918817
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.004855894	0.18010508663918817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004855894	0.18010508663918817
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.18010508663918817
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.004855894	0.18010508663918817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004855894	0.18010508663918817
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004851759000000001	0.1799517195077695
ADIPOSIS DOLOROSA	0.004851759000000001	0.1799517195077695
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.1799517195077695
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.1799517195077695
DILATED CARDIOMYOPATHY WITH ATAXIA	0.004851759000000001	0.1799517195077695
RETT SYNDROME	0.004851759000000001	0.1799517195077695
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004851759000000001	0.1799517195077695
DYSOSTEOSCLEROSIS	0.004851759000000001	0.1799517195077695
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.004851759000000001	0.1799517195077695
TRIPLE A SYNDROME	0.004851759000000001	0.1799517195077695
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004851759000000001	0.1799517195077695
BEHÃ‡ET DISEASE	0.004851759000000001	0.1799517195077695
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.1799517195077695
RETT SYNDROME; RTT	0.004851759000000001	0.1799517195077695
KRABBE DISEASE	0.004851759000000001	0.1799517195077695
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.1799517195077695
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.004851759000000001	0.1799517195077695
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.004851759000000001	0.1799517195077695
CADASIL	0.004851759000000001	0.1799517195077695
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.004851759000000001	0.1799517195077695
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.004851759000000001	0.1799517195077695
WOLFRAM SYNDROME	0.004851759000000001	0.1799517195077695
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.1799517195077695
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.004851759000000001	0.1799517195077695
XERODERMA PIGMENTOSUM	0.004851759000000001	0.1799517195077695
WHIPPLE DISEASE	0.004851759000000001	0.1799517195077695
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.1799517195077695
NASU-HAKOLA DISEASE	0.004851759000000001	0.1799517195077695
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.004851759000000001	0.1799517195077695
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.1799517195077695
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.1799517195077695
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.1799517195077695
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.004851759000000001	0.1799517195077695
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004851759000000001	0.1799517195077695
ALEXANDER DISEASE	0.004851759000000001	0.1799517195077695
RETT SYNDROME, CONGENITAL VARIANT	0.004851759000000001	0.1799517195077695
14Q12 MICRODELETION SYNDROME	0.004851759000000001	0.1799517195077695
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.004851759000000001	0.1799517195077695
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004851759000000001	0.1799517195077695
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.0045234030000000005	0.1677729969432948
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.0045234030000000005	0.1677729969432948
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.0045234030000000005	0.1677729969432948
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0045234030000000005	0.1677729969432948
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0045234030000000005	0.1677729969432948
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0045234030000000005	0.1677729969432948
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004523403	0.16777299694329478
JOUBERT SYNDROME WITH RENAL DEFECT	0.004523403	0.16777299694329478
ADULT-ONSET DYSTONIA-PARKINSONISM	0.004523403	0.16777299694329478
JOUBERT SYNDROME WITH OCULAR DEFECT	0.004523403	0.16777299694329478
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004523403	0.16777299694329478
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.004523403	0.16777299694329478
JABERI-ELAHI SYNDROME; JABELS	0.004523403	0.16777299694329478
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.004523403	0.16777299694329478
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.004523403	0.16777299694329478
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004523403	0.16777299694329478
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.004523403	0.16777299694329478
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004523403	0.16777299694329478
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004523403	0.16777299694329478
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.004523403	0.16777299694329478
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.004523403	0.16777299694329478
OROFACIODIGITAL SYNDROME TYPE 6	0.004523403	0.16777299694329478
GALACTOSEMIA	0.004523403	0.16777299694329478
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004523403	0.16777299694329478
JOUBERT SYNDROME	0.004523403	0.16777299694329478
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.004523403	0.16777299694329478
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.004523403	0.16777299694329478
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.004523403	0.16777299694329478
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004523403	0.16777299694329478
SIALIDOSIS TYPE 2	0.004523403	0.16777299694329478
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.004523403	0.16777299694329478
PELIZAEUS-MERZBACHER DISEASE	0.004523403	0.16777299694329478
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.1598704912307308
TRISOMY 5P	0.00431034	0.1598704912307308
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.1598704912307308
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.1598704912307308
DYSOSTEOSCLEROSIS	0.00431034	0.1598704912307308
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.1598704912307308
REFSUM DISEASE	0.00431034	0.1598704912307308
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00431034	0.1598704912307308
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.1598704912307308
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.1598704912307308
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.1598704912307308
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.1598704912307308
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.1598704912307308
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.1598704912307308
DOWN SYNDROME	0.00431034	0.1598704912307308
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.1598704912307308
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.003981984	0.14769176866625608
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003981984	0.14769176866625608
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003981984	0.14769176866625608
PEROXISOME BIOGENESIS DISORDER 5B	0.003981984	0.14769176866625608
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.003981984	0.14769176866625608
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.003981984	0.14769176866625608
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003981984	0.14769176866625608
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003981984	0.14769176866625608
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.003981984	0.14769176866625608
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003981984	0.14769176866625608
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.003981984	0.14769176866625608
12Q14 MICRODELETION SYNDROME	0.003981984	0.14769176866625608
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.003981984	0.14769176866625608
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.003981984	0.14769176866625608
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.003981984	0.14769176866625608
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003981984	0.14769176866625608
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003981984	0.14769176866625608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.003977849	0.14753840153483747
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.003977849	0.14753840153483747
NIPAH VIRUS DISEASE	0.003977849	0.14753840153483747
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.003977849	0.14753840153483747
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.003977849	0.14753840153483747
TSH-SECRETING PITUITARY ADENOMA	0.003977849	0.14753840153483747
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003977849	0.14753840153483747
GM1 GANGLIOSIDOSIS	0.003977849	0.14753840153483747
ATAXIA-TELANGIECTASIA	0.003977849	0.14753840153483747
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.003977849	0.14753840153483747
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.003977849	0.14753840153483747
SIALIDOSIS TYPE 1	0.003977849	0.14753840153483747
COCKAYNE SYNDROME A; CSA	0.003977849	0.14753840153483747
KALLMANN SYNDROME	0.003977849	0.14753840153483747
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.003977849	0.14753840153483747
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003977849	0.14753840153483747
TYROSINEMIA TYPE 2	0.003977849	0.14753840153483747
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.003977849	0.14753840153483747
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003977849	0.14753840153483747
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.003977849	0.14753840153483747
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.003977849	0.14753840153483747
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.003977849	0.14753840153483747
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.003977849	0.14753840153483747
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003977849	0.14753840153483747
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.003977849	0.14753840153483747
KUFOR-RAKEB SYNDROME	0.003977849	0.14753840153483747
SNEDDON SYNDROME	0.003977849	0.14753840153483747
INSULINOMA	0.003977849	0.14753840153483747
ENCEPHALITIS LETHARGICA	0.003977849	0.14753840153483747
OROFACIODIGITAL SYNDROME TYPE 1	0.003977849	0.14753840153483747
CYSTATHIONINURIA	0.003977849	0.14753840153483747
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.003977849	0.14753840153483747
SCRUB TYPHUS	0.003977849	0.14753840153483747
COCKAYNE SYNDROME	0.003977849	0.14753840153483747
CRIGLER-NAJJAR SYNDROME TYPE 1	0.003977849	0.14753840153483747
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.003977849	0.14753840153483747
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.003977849	0.14753840153483747
OPTIC ATROPHY 2	0.00343643	0.12745717325779873
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00343643	0.12745717325779873
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00343643	0.12745717325779873
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00343643	0.12745717325779873
DYSTONIA 11, MYOCLONIC	0.00343643	0.12745717325779873
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00343643	0.12745717325779873
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.00343643	0.12745717325779873
CEREBELLAR HYPOPLASIA	0.00343643	0.12745717325779873
NON-FUNCTIONING PARAGANGLIOMA	0.00343643	0.12745717325779873
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00343643	0.12745717325779873
SÃ‰ZARY SYNDROME	0.00343643	0.12745717325779873
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00343643	0.12745717325779873
PRIMARY DYSTONIA, DYT2 TYPE	0.00343643	0.12745717325779873
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00343643	0.12745717325779873
CLASSIC GALACTOSEMIA	0.00343643	0.12745717325779873
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00343643	0.12745717325779873
MYOPATHY, SPHEROID BODY	0.00343643	0.12745717325779873
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00343643	0.12745717325779873
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00343643	0.12745717325779873
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00343643	0.12745717325779873
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00343643	0.12745717325779873
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00343643	0.12745717325779873
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00343643	0.12745717325779873
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00343643	0.12745717325779873
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00343643	0.12745717325779873
TETANUS	0.00343643	0.12745717325779873
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00343643	0.12745717325779873
BEHR SYNDROME	0.00343643	0.12745717325779873
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.00343643	0.12745717325779873
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00343643	0.12745717325779873
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00343643	0.12745717325779873
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00343643	0.12745717325779873
EPISODIC ATAXIA, TYPE 1; EA1	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA TYPE 14	0.00343643	0.12745717325779873
DYSTONIA 3, TORSION, X-LINKED	0.00343643	0.12745717325779873
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00343643	0.12745717325779873
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00343643	0.12745717325779873
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00343643	0.12745717325779873
TYPHOID	0.00343643	0.12745717325779873
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00343643	0.12745717325779873
WILSON DISEASE	0.00343643	0.12745717325779873
SPASTIC PARAPARESIS AND DEAFNESS	0.00343643	0.12745717325779873
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00343643	0.12745717325779873
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00343643	0.12745717325779873
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00343643	0.12745717325779873
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00343643	0.12745717325779873
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00343643	0.12745717325779873
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00343643	0.12745717325779873
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00343643	0.12745717325779873
DYSTONIA 13, TORSION	0.00343643	0.12745717325779873
ACERULOPLASMINEMIA	0.00343643	0.12745717325779873
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00343643	0.12745717325779873
PRIMARY ORTHOSTATIC TREMOR	0.00343643	0.12745717325779873
GLUTATHIONURIA	0.00343643	0.12745717325779873
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00343643	0.12745717325779873
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA TYPE 37	0.00343643	0.12745717325779873
NEUROLEPTIC MALIGNANT SYNDROME	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA 42	0.00343643	0.12745717325779873
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00343643	0.12745717325779873
THYROTOXIC PERIODIC PARALYSIS	0.00343643	0.12745717325779873
PARKINSON DISEASE, LATE-ONSET; PD	0.00343643	0.12745717325779873
PERRY SYNDROME	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00343643	0.12745717325779873
PERRY SYNDROME	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00343643	0.12745717325779873
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00343643	0.12745717325779873
AMISH NEMALINE MYOPATHY	0.00343643	0.12745717325779873
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00343643	0.12745717325779873
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00343643	0.12745717325779873
PROGRESSIVE SUPRANUCLEAR PALSY	0.00343643	0.12745717325779873
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00343643	0.12745717325779873
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00343643	0.12745717325779873
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00343643	0.12745717325779873
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00343643	0.12745717325779873
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00343643	0.12745717325779873
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00343643	0.12745717325779873
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA TYPE 31	0.00343643	0.12745717325779873
PARKINSON DISEASE 21; PARK21	0.00343643	0.12745717325779873
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA 18	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00343643	0.12745717325779873
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00343643	0.12745717325779873
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00343643	0.12745717325779873
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00343643	0.12745717325779873
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.04031582368549607
ARGININOSUCCINIC ACIDURIA	0.001086973	0.04031582368549607
TETRASOMY 5P	0.001086973	0.04031582368549607
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.04031582368549607
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.04031582368549607
MONOSOMY 9P	0.001086973	0.04031582368549607
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.04031582368549607
ISOVALERIC ACIDEMIA	0.001086973	0.04031582368549607
17Q12 MICRODELETION SYNDROME	0.001086973	0.04031582368549607
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.04031582368549607
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.04031582368549607
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.04031582368549607
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.04031582368549607
KETOADIPICACIDURIA	0.001086973	0.04031582368549607
20P12.3 MICRODELETION SYNDROME	0.001086973	0.04031582368549607
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.04031582368549607
15Q14 MICRODELETION SYNDROME	0.001086973	0.04031582368549607
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.04031582368549607
NARP SYNDROME	0.001086973	0.04031582368549607
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001086973	0.04031582368549607
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.04031582368549607
BOHRING-OPITZ SYNDROME	0.001086973	0.04031582368549607
C SYNDROME	0.001086973	0.04031582368549607
LATHOSTEROLOSIS	0.001086973	0.04031582368549607
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.04031582368549607
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.04031582368549607
KOOLEN-DE VRIES SYNDROME	0.001086973	0.04031582368549607
POTOCKI-SHAFFER SYNDROME	0.001086973	0.04031582368549607
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04031582368549607
L1 SYNDROME	0.001086973	0.04031582368549607
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.04031582368549607
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.04031582368549607
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001086973	0.04031582368549607
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.04031582368549607
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.04031582368549607
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.04031582368549607
SRD5A3-CDG	0.001086973	0.04031582368549607
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.04031582368549607
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.04031582368549607
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.04031582368549607
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.04031582368549607
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.04031582368549607
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.04031582368549607
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.04031582368549607
FILIPPI SYNDROME	0.001086973	0.04031582368549607
HARTNUP DISEASE	0.001086973	0.04031582368549607
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.04031582368549607
ADAMS-OLIVER SYNDROME 1; AOS1	0.001086973	0.04031582368549607
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.04031582368549607
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001086973	0.04031582368549607
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.04031582368549607
ALG11-CDG	0.001086973	0.04031582368549607
XP21 MICRODELETION SYNDROME	0.001086973	0.04031582368549607
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.04031582368549607
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.04031582368549607
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.001086973	0.04031582368549607
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.04031582368549607
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.04031582368549607
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.001086973	0.04031582368549607
DONNAI-BARROW SYNDROME	0.001086973	0.04031582368549607
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04031582368549607
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001086973	0.04031582368549607
MACDERMOT-WINTER SYNDROME	0.001086973	0.04031582368549607
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.001086973	0.04031582368549607
HOLOPROSENCEPHALY	0.001086973	0.04031582368549607
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.04031582368549607
VICI SYNDROME	0.001086973	0.04031582368549607
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.04031582368549607
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.04031582368549607
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.04031582368549607
CRANIOPHARYNGIOMA	0.001086973	0.04031582368549607
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.04031582368549607
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.04031582368549607
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.04031582368549607
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.04031582368549607
COACH SYNDROME	0.001086973	0.04031582368549607
SEVERE CANAVAN DISEASE	0.001086973	0.04031582368549607
WILSON-TURNER SYNDROME	0.001086973	0.04031582368549607
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.04031582368549607
STT3A-CDG	0.001086973	0.04031582368549607
STT3B-CDG	0.001086973	0.04031582368549607
HYDRANENCEPHALY	0.001086973	0.04031582368549607
CITRULLINEMIA, CLASSIC	0.001086973	0.04031582368549607
SSR4-CDG	0.001086973	0.04031582368549607
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.04031582368549607
2P21 MICRODELETION SYNDROME	0.001086973	0.04031582368549607
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.04031582368549607
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001086973	0.04031582368549607
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001086973	0.04031582368549607
1P36 DELETION SYNDROME	0.001086973	0.04031582368549607
MONOSOMY 18Q	0.001086973	0.04031582368549607
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.001086973	0.04031582368549607
GRISCELLI SYNDROME	0.001086973	0.04031582368549607
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.04031582368549607
MOSAIC TRISOMY 14	0.001086973	0.04031582368549607
GAUCHER DISEASE, TYPE II	0.001086973	0.04031582368549607
LEBER CONGENITAL AMAUROSIS	0.001086973	0.04031582368549607
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.04031582368549607
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001086973	0.04031582368549607
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.04031582368549607
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04031582368549607
DUANE RETRACTION SYNDROME	0.001086973	0.04031582368549607
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.04031582368549607
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.04031582368549607
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.04031582368549607
KBG SYNDROME	0.001086973	0.04031582368549607
HARTNUP DISORDER	0.001086973	0.04031582368549607
PALLISTER-HALL SYNDROME	0.001086973	0.04031582368549607
COHEN SYNDROME	0.001086973	0.04031582368549607
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.04031582368549607
FUCOSIDOSIS	0.001086973	0.04031582368549607
RUVALCABA SYNDROME	0.001086973	0.04031582368549607
DISTAL MONOSOMY 1Q	0.001086973	0.04031582368549607
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.04031582368549607
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.04031582368549607
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.04031582368549607
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.04031582368549607
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.001086973	0.04031582368549607
DISTAL MONOSOMY 19P13.3	0.001086973	0.04031582368549607
COFFIN-SIRIS SYNDROME 1; CSS1	0.001086973	0.04031582368549607
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.04031582368549607
ALSTRÃ–M SYNDROME	0.001086973	0.04031582368549607
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.04031582368549607
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.04031582368549607
COWDEN SYNDROME	0.001086973	0.04031582368549607
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.04031582368549607
VICI SYNDROME; VICIS	0.001086973	0.04031582368549607
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.04031582368549607
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.04031582368549607
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.04031582368549607
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001086973	0.04031582368549607
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.04031582368549607
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.04031582368549607
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.04031582368549607
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.04031582368549607
COFFIN-SIRIS SYNDROME	0.001086973	0.04031582368549607
KABUKI SYNDROME 1	0.001086973	0.04031582368549607
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.04031582368549607
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.04031582368549607
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.04031582368549607
DYSTONIA-APHONIA SYNDROME	0.001086973	0.04031582368549607
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.04031582368549607
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001086973	0.04031582368549607
XQ21 MICRODELETION SYNDROME	0.001086973	0.04031582368549607
PHACE SYNDROME	0.001086973	0.04031582368549607
TARP SYNDROME	0.001086973	0.04031582368549607
MAPLE SYRUP URINE DISEASE	0.001086973	0.04031582368549607
EAST SYNDROME	0.001086973	0.04031582368549607
PITT-HOPKINS SYNDROME	0.001086973	0.04031582368549607
MEVALONIC ACIDURIA	0.001086973	0.04031582368549607
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001086973	0.04031582368549607
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.04031582368549607
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.04031582368549607
NETHERTON SYNDROME	0.001086973	0.04031582368549607
MICRO SYNDROME	0.001086973	0.04031582368549607
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.04031582368549607
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.001086973	0.04031582368549607
CEDNIK SYNDROME	0.001086973	0.04031582368549607
WYBURN-MASON SYNDROME	0.001086973	0.04031582368549607
2Q31.1 MICRODELETION SYNDROME	0.001086973	0.04031582368549607
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.04031582368549607
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.04031582368549607
MAN1B1-CDG	0.001086973	0.04031582368549607
KBG SYNDROME	0.001086973	0.04031582368549607
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.04031582368549607
6Q25 MICRODELETION SYNDROME	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.04031582368549607
8P11.2 DELETION SYNDROME	0.001086973	0.04031582368549607
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.04031582368549607
RECOMBINANT 8 SYNDROME	0.001086973	0.04031582368549607
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.04031582368549607
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.04031582368549607
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.04031582368549607
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.04031582368549607
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.04031582368549607
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.04031582368549607
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001086973	0.04031582368549607
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.04031582368549607
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.04031582368549607
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.04031582368549607
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.04031582368549607
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.04031582368549607
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.04031582368549607
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.04031582368549607
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.04031582368549607
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04031582368549607
ELEJALDE DISEASE	0.001086973	0.04031582368549607
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.04031582368549607
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.04031582368549607
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.04031582368549607
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.04031582368549607
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.04031582368549607
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.04031582368549607
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.04031582368549607
EMANUEL SYNDROME	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.04031582368549607
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.04031582368549607
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001086973	0.04031582368549607
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.04031582368549607
PFEIFFER SYNDROME TYPE 2	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001086973	0.04031582368549607
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.04031582368549607
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.04031582368549607
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.04031582368549607
SULFOCYSTEINURIA	0.001086973	0.04031582368549607
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.04031582368549607
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.04031582368549607
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.04031582368549607
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.04031582368549607
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.04031582368549607
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.04031582368549607
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.04031582368549607
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.04031582368549607
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001086973	0.04031582368549607
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.04031582368549607
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.04031582368549607
HOLOPROSENCEPHALY 7	0.001086973	0.04031582368549607
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.04031582368549607
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.04031582368549607
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.04031582368549607
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.04031582368549607
LISSENCEPHALY 8; LIS8	0.001086973	0.04031582368549607
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.04031582368549607
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.04031582368549607
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.04031582368549607
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.04031582368549607
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.04031582368549607
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.04031582368549607
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.04031582368549607
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.04031582368549607
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.04031582368549607
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.04031582368549607
PHACE ASSOCIATION	0.001086973	0.04031582368549607
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.04031582368549607
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.04031582368549607
PHELAN-MCDERMID SYNDROME	0.001086973	0.04031582368549607
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.04031582368549607
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.04031582368549607
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.04031582368549607
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.04031582368549607
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.04031582368549607
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.04031582368549607
HEART AND BRAIN MALFORMATION SYNDROME	0.001086973	0.04031582368549607
COFFIN-SIRIS SYNDROME 5	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.04031582368549607
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.04031582368549607
LEIGH SYNDROME; LS	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.04031582368549607
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.04031582368549607
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.04031582368549607
MEHMO SYNDROME; MEHMO	0.001086973	0.04031582368549607
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.04031582368549607
MIRAGE SYNDROME; MIRAGE	0.001086973	0.04031582368549607
GENITOPATELLAR SYNDROME	0.001086973	0.04031582368549607
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.04031582368549607
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.04031582368549607
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.04031582368549607
KEUTEL SYNDROME	0.001086973	0.04031582368549607
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.04031582368549607
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.04031582368549607
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.04031582368549607
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.04031582368549607
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.04031582368549607
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.04031582368549607
ALG1-CDG	0.001086973	0.04031582368549607
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.04031582368549607
SCHIZENCEPHALY	0.001086973	0.04031582368549607
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.04031582368549607
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.04031582368549607
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.04031582368549607
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.04031582368549607
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.04031582368549607
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.04031582368549607
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.04031582368549607
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.04031582368549607
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.04031582368549607
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.04031582368549607
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.04031582368549607
LISSENCEPHALY 4	0.001086973	0.04031582368549607
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.04031582368549607
SCHAAF-YANG SYNDROME; SHFYNG	0.001086973	0.04031582368549607
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.04031582368549607
PEHO SYNDROME; PEHO	0.001086973	0.04031582368549607
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.04031582368549607
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001086973	0.04031582368549607
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.04031582368549607
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.04031582368549607
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.04031582368549607
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.04031582368549607
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.04031582368549607
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.04031582368549607
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001086973	0.04031582368549607
COFFIN-SIRIS SYNDROME 2; CSS2	0.001086973	0.04031582368549607
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.04031582368549607
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001086973	0.04031582368549607
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.04031582368549607
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001086973	0.04031582368549607
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.04031582368549607
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.04031582368549607
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001086973	0.04031582368549607
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.04031582368549607
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.04031582368549607
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.04031582368549607
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.04031582368549607
PETERS-PLUS SYNDROME; PTRPLS	0.001086973	0.04031582368549607
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.04031582368549607
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.04031582368549607
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.04031582368549607
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001086973	0.04031582368549607
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.04031582368549607
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.04031582368549607
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.04031582368549607
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001086973	0.04031582368549607
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.04031582368549607
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.04031582368549607
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.04031582368549607
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.04031582368549607
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.04031582368549607
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.04031582368549607
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.04031582368549607
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.04031582368549607
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.04031582368549607
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.04031582368549607
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.04031582368549607
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.04031582368549607
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001086973	0.04031582368549607
ALG3-CDG	0.001086973	0.04031582368549607
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.04031582368549607
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.04031582368549607
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.04031582368549607
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.04031582368549607
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.04031582368549607
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001086973	0.04031582368549607
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.04031582368549607
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.04031582368549607
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.04031582368549607
PMM2-CDG	0.001086973	0.04031582368549607
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.04031582368549607
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.04031582368549607
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.04031582368549607
PROPIONIC ACIDEMIA	0.001086973	0.04031582368549607
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.04031582368549607
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.04031582368549607
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.04031582368549607
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001086973	0.04031582368549607
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.04031582368549607
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.04031582368549607
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.04031582368549607
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.04031582368549607
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.04031582368549607
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.001086973	0.04031582368549607
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001086973	0.04031582368549607
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.04031582368549607
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.04031582368549607
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.04031582368549607
DPAGT1-CDG	0.001086973	0.04031582368549607
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.04031582368549607
AL KAISSI SYNDROME; ALKAS	0.001086973	0.04031582368549607
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.04031582368549607
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.04031582368549607
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.04031582368549607
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.04031582368549607
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.04031582368549607
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001086973	0.04031582368549607
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.04031582368549607
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001086973	0.04031582368549607
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.04031582368549607
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.04031582368549607
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.04031582368549607
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.04031582368549607
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.04031582368549607
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.001086973	0.04031582368549607
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001086973	0.04031582368549607
WIEACKER-WOLFF SYNDROME	0.001086973	0.04031582368549607
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.04031582368549607
CHROMOSOME 1P35 DELETION SYNDROME	0.001086973	0.04031582368549607
TIMOTHY SYNDROME; TS	0.001086973	0.04031582368549607
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.04031582368549607
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.04031582368549607
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.04031582368549607
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.04031582368549607
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.04031582368549607
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.04031582368549607
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.04031582368549607
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.04031582368549607
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.04031582368549607
6Q TERMINAL DELETION SYNDROME	0.001086973	0.04031582368549607
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.04031582368549607
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001086973	0.04031582368549607
WAISMAN SYNDROME; WSMN	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001086973	0.04031582368549607
WALKER-WARBURG SYNDROME	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.04031582368549607
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.04031582368549607
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.04031582368549607
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.04031582368549607
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001086973	0.04031582368549607
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.04031582368549607
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.04031582368549607
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001086973	0.04031582368549607
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.04031582368549607
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.04031582368549607
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001086973	0.04031582368549607
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.04031582368549607
BOHRING-OPITZ SYNDROME	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.04031582368549607
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.04031582368549607
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.04031582368549607
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.001086973	0.04031582368549607
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.04031582368549607
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.04031582368549607
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.04031582368549607
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001086973	0.04031582368549607
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.04031582368549607
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.04031582368549607
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.04031582368549607
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001086973	0.04031582368549607
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001086973	0.04031582368549607
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.001086973	0.04031582368549607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.04031582368549607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.04031582368549607
SALLA DISEASE	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.04031582368549607
CODAS SYNDROME	0.001086973	0.04031582368549607
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.04031582368549607
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.04031582368549607
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.04031582368549607
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.04031582368549607
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.04031582368549607
PETTIGREW SYNDROME	0.001086973	0.04031582368549607
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.04031582368549607
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.04031582368549607
BAND HETEROTOPIA; BH	0.001086973	0.04031582368549607
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.04031582368549607
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.04031582368549607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.04031582368549607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.04031582368549607
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.02023459540845736
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.02023459540845736
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02023459540845736
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.02023459540845736
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.02023459540845736
NOONAN SYNDROME 6; NS6	0.000545554	0.02023459540845736
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.02023459540845736
CURRARINO SYNDROME	0.000545554	0.02023459540845736
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.02023459540845736
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.02023459540845736
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.02023459540845736
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.02023459540845736
SAY-BARBER-MILLER SYNDROME	0.000545554	0.02023459540845736
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02023459540845736
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02023459540845736
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.02023459540845736
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.02023459540845736
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.02023459540845736
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.02023459540845736
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.02023459540845736
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.02023459540845736
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.02023459540845736
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.02023459540845736
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.02023459540845736
HADZISELIMOVIC SYNDROME	0.000545554	0.02023459540845736
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.02023459540845736
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02023459540845736
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02023459540845736
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.02023459540845736
CHAR SYNDROME	0.000545554	0.02023459540845736
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.000545554	0.02023459540845736
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.02023459540845736
SENIOR-LOKEN SYNDROME	0.000545554	0.02023459540845736
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02023459540845736
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02023459540845736
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02023459540845736
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02023459540845736
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02023459540845736
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02023459540845736
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.02023459540845736
CONGENITAL VARICELLA SYNDROME	0.000545554	0.02023459540845736
JOUBERT SYNDROME 15	0.000545554	0.02023459540845736
TETRASOMY X	0.000545554	0.02023459540845736
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.02023459540845736
HOLOPROSENCEPHALY 11	0.000545554	0.02023459540845736
JOUBERT SYNDROME 14	0.000545554	0.02023459540845736
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02023459540845736
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.02023459540845736
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.02023459540845736
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02023459540845736
CHAR SYNDROME	0.000545554	0.02023459540845736
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.02023459540845736
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.02023459540845736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02023459540845736
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.02023459540845736
HURLER SYNDROME	0.000545554	0.02023459540845736
ALSTROM SYNDROME; ALMS	0.000545554	0.02023459540845736
3MC SYNDROME 2	0.000545554	0.02023459540845736
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02023459540845736
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.02023459540845736
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.02023459540845736
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.02023459540845736
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.02023459540845736
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02023459540845736
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02023459540845736
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02023459540845736
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02023459540845736
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.02023459540845736
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.02023459540845736
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.02023459540845736
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02023459540845736
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.02023459540845736
SEPTOOPTIC DYSPLASIA	0.000545554	0.02023459540845736
TARP SYNDROME; TARPS	0.000545554	0.02023459540845736
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.02023459540845736
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.02023459540845736
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02023459540845736
BARATELA-SCOTT SYNDROME	0.000545554	0.02023459540845736
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.02023459540845736
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.02023459540845736
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.02023459540845736
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.02023459540845736
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02023459540845736
ROTHMUND-THOMSON SYNDROME	0.000545554	0.02023459540845736
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.02023459540845736
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02023459540845736
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.02023459540845736
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02023459540845736
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.02023459540845736
REVESZ SYNDROME	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.02023459540845736
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.02023459540845736
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.02023459540845736
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.02023459540845736
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02023459540845736
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02023459540845736
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02023459540845736
DE BARSY SYNDROME	0.000545554	0.02023459540845736
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02023459540845736
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.02023459540845736
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.02023459540845736
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.02023459540845736
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.02023459540845736
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02023459540845736
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.02023459540845736
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.02023459540845736
LARSEN-LIKE SYNDROME	0.000545554	0.02023459540845736
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.02023459540845736
CDAGS SYNDROME	0.000545554	0.02023459540845736
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02023459540845736
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.02023459540845736
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.02023459540845736
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.02023459540845736
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.02023459540845736
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.02023459540845736
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02023459540845736
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02023459540845736
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.02023459540845736
LIG4 SYNDROME	0.000545554	0.02023459540845736
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.02023459540845736
FRIAS SYNDROME	0.000545554	0.02023459540845736
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.02023459540845736
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02023459540845736
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.02023459540845736
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02023459540845736
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.02023459540845736
YUNIS-VARON SYNDROME	0.000545554	0.02023459540845736
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.02023459540845736
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.02023459540845736
PROPIONIC ACIDEMIA	0.000545554	0.02023459540845736
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02023459540845736
ISOLATED PLAGIOCEPHALY	0.000545554	0.02023459540845736
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.02023459540845736
CURRY-JONES SYNDROME	0.000545554	0.02023459540845736
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.02023459540845736
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.02023459540845736
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02023459540845736
JOUBERT SYNDROME 2	0.000545554	0.02023459540845736
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02023459540845736
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02023459540845736
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.02023459540845736
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02023459540845736
LIG4 SYNDROME	0.000545554	0.02023459540845736
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.02023459540845736
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.02023459540845736
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.02023459540845736
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.02023459540845736
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.02023459540845736
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.02023459540845736
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.02023459540845736
NOONAN SYNDROME 2; NS2	0.000545554	0.02023459540845736
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.02023459540845736
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.02023459540845736
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02023459540845736
FRONTOOCULAR SYNDROME	0.000545554	0.02023459540845736
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02023459540845736
HURLER SYNDROME	0.000545554	0.02023459540845736
48,XYYY SYNDROME	0.000545554	0.02023459540845736
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.02023459540845736
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02023459540845736
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.02023459540845736
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.02023459540845736
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02023459540845736
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.02023459540845736
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.02023459540845736
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02023459540845736
MOSAIC TRISOMY 9	0.000545554	0.02023459540845736
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02023459540845736
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.02023459540845736
BRESEK SYNDROME	0.000545554	0.02023459540845736
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02023459540845736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.02023459540845736
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02023459540845736
WEAVER SYNDROME	0.000545554	0.02023459540845736
NOONAN SYNDROME 3; NS3	0.000545554	0.02023459540845736
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.02023459540845736
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.02023459540845736
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02023459540845736
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02023459540845736
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02023459540845736
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.02023459540845736
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02023459540845736
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02023459540845736
JOUBERT SYNDROME 10	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02023459540845736
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.02023459540845736
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02023459540845736
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.02023459540845736
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.02023459540845736
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02023459540845736
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.02023459540845736
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02023459540845736
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.02023459540845736
CONGENITAL HYPOTHYROIDISM	0.000545554	0.02023459540845736
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.02023459540845736
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02023459540845736
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02023459540845736
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02023459540845736
OGDEN SYNDROME; OGDNS	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.02023459540845736
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.02023459540845736
LOWRY-MACLEAN SYNDROME	0.000545554	0.02023459540845736
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.02023459540845736
TREACHER-COLLINS SYNDROME	0.000545554	0.02023459540845736
JOUBERT SYNDROME 8	0.000545554	0.02023459540845736
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02023459540845736
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.02023459540845736
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02023459540845736
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.02023459540845736
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.02023459540845736
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.02023459540845736
JOUBERT SYNDROME 7	0.000545554	0.02023459540845736
FRIED SYNDROME	0.000545554	0.02023459540845736
FARBER DISEASE	0.000545554	0.02023459540845736
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.02023459540845736
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.02023459540845736
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.02023459540845736
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.02023459540845736
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.02023459540845736
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02023459540845736
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.02023459540845736
NOONAN SYNDROME 5; NS5	0.000545554	0.02023459540845736
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.02023459540845736
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.02023459540845736
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.02023459540845736
TRISOMY 18	0.000545554	0.02023459540845736
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.02023459540845736
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.02023459540845736
WAARDENBURG-SHAH SYNDROME	0.000545554	0.02023459540845736
OROFACIODIGITAL SYNDROME VI	0.000545554	0.02023459540845736
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.02023459540845736
MEVALONIC ACIDURIA; MEVA	0.000545554	0.02023459540845736
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.02023459540845736
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.02023459540845736
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02023459540845736
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02023459540845736
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.02023459540845736
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.02023459540845736
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.02023459540845736
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.02023459540845736
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.02023459540845736
FANCONI ANEMIA	0.000545554	0.02023459540845736
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.02023459540845736
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.02023459540845736
JOUBERT SYNDROME 6	0.000545554	0.02023459540845736
SYNDROMIC DIARRHEA	0.000545554	0.02023459540845736
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02023459540845736
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.02023459540845736
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.02023459540845736
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.02023459540845736
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.02023459540845736
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.02023459540845736
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.02023459540845736
FETAL HYDANTOIN SYNDROME	0.000545554	0.02023459540845736
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.02023459540845736
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.02023459540845736
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.02023459540845736
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.02023459540845736
TOLUENE EMBRYOPATHY	0.000545554	0.02023459540845736
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02023459540845736
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.02023459540845736
DISTAL MONOSOMY 6P	0.000545554	0.02023459540845736
HOLMES-GANG SYNDROME	0.000545554	0.02023459540845736
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02023459540845736
OCCIPITAL HORN SYNDROME	0.000545554	0.02023459540845736
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.02023459540845736
JOUBERT SYNDROME 28	0.000545554	0.02023459540845736
JOUBERT SYNDROME 27	0.000545554	0.02023459540845736
HYDROXYKYNURENINURIA	0.000545554	0.02023459540845736
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.02023459540845736
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.02023459540845736
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02023459540845736
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02023459540845736
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.02023459540845736
MECKEL SYNDROME 13; MKS13	0.000545554	0.02023459540845736
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.02023459540845736
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02023459540845736
RAHMAN SYNDROME	0.000545554	0.02023459540845736
DISTAL TRISOMY 18Q	0.000545554	0.02023459540845736
MUCOLIPIDOSIS IV; ML4	0.000545554	0.02023459540845736
6Q16 MICRODELETION SYNDROME	0.000545554	0.02023459540845736
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.02023459540845736
DISTAL TRISOMY 6P	0.000545554	0.02023459540845736
TRISOMY 8Q	0.000545554	0.02023459540845736
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.02023459540845736
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02023459540845736
DYSKERATOSIS CONGENITA	0.000545554	0.02023459540845736
TEMTAMY SYNDROME	0.000545554	0.02023459540845736
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.02023459540845736
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02023459540845736
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000545554	0.02023459540845736
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.02023459540845736
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.02023459540845736
MEIER-GORLIN SYNDROME 7	0.000545554	0.02023459540845736
MEDULLOBLASTOMA	0.000545554	0.02023459540845736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02023459540845736
ZECHI-CEIDE SYNDROME	0.000545554	0.02023459540845736
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.02023459540845736
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02023459540845736
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.02023459540845736
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.02023459540845736
LAMB-SHAFFER SYNDROME	0.000545554	0.02023459540845736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02023459540845736
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.02023459540845736
JOUBERT SYNDROME 26	0.000545554	0.02023459540845736
JOUBERT SYNDROME 25	0.000545554	0.02023459540845736
SECKEL SYNDROME 9; SCKL9	0.000545554	0.02023459540845736
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.02023459540845736
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.02023459540845736
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.02023459540845736
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.02023459540845736
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02023459540845736
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.02023459540845736
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.02023459540845736
HYPERTRICHOSIS CUBITI	0.000545554	0.02023459540845736
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.02023459540845736
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.02023459540845736
EVEN-PLUS SYNDROME	0.000545554	0.02023459540845736
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02023459540845736
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.02023459540845736
FLOATING-HARBOR SYNDROME	0.000545554	0.02023459540845736
MONOSOMY 13Q34	0.000545554	0.02023459540845736
ALPHA-MANNOSIDOSIS	0.000545554	0.02023459540845736
COLE-CARPENTER SYNDROME	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.02023459540845736
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02023459540845736
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02023459540845736
GERMAN SYNDROME	0.000545554	0.02023459540845736
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02023459540845736
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.02023459540845736
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02023459540845736
CUTIS LAXA	0.000545554	0.02023459540845736
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.02023459540845736
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.02023459540845736
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.02023459540845736
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02023459540845736
NETHERTON SYNDROME; NETH	0.000545554	0.02023459540845736
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.02023459540845736
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.02023459540845736
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.02023459540845736
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02023459540845736
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.02023459540845736
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02023459540845736
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02023459540845736
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.02023459540845736
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.02023459540845736
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.02023459540845736
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.02023459540845736
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.02023459540845736
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02023459540845736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.02023459540845736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02023459540845736
PETERS PLUS SYNDROME	0.000545554	0.02023459540845736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02023459540845736
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.02023459540845736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.02023459540845736
RABSON-MENDENHALL SYNDROME	0.000545554	0.02023459540845736
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.02023459540845736
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.02023459540845736
AURICULOCONDYLAR SYNDROME	0.000545554	0.02023459540845736
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.02023459540845736
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.02023459540845736
PENTASOMY X	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02023459540845736
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.02023459540845736
NOONAN SYNDROME 11; NS11	0.000545554	0.02023459540845736
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.02023459540845736
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.02023459540845736
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.02023459540845736
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.02023459540845736
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.02023459540845736
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.02023459540845736
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.02023459540845736
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.02023459540845736
TRANSALDOLASE DEFICIENCY	0.000545554	0.02023459540845736
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.02023459540845736
WOLMAN DISEASE	0.000545554	0.02023459540845736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.02023459540845736
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02023459540845736
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02023459540845736
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02023459540845736
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02023459540845736
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.02023459540845736
HYDROXYKYNURENINURIA	0.000545554	0.02023459540845736
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.02023459540845736
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.02023459540845736
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02023459540845736
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.02023459540845736
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.02023459540845736
THYROID ECTOPIA	0.000545554	0.02023459540845736
ATHYREOSIS	0.000545554	0.02023459540845736
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.02023459540845736
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02023459540845736
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.02023459540845736
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.02023459540845736
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.02023459540845736
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.02023459540845736
DISTAL MONOSOMY 9P	0.000545554	0.02023459540845736
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.02023459540845736
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.02023459540845736
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.02023459540845736
THYROID HEMIAGENESIS	0.000545554	0.02023459540845736
THYROID HYPOPLASIA	0.000545554	0.02023459540845736
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.02023459540845736
DEXTROCARDIA	0.000545554	0.02023459540845736
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.02023459540845736
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02023459540845736
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.02023459540845736
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.02023459540845736
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.02023459540845736
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.02023459540845736
ARIMA SYNDROME	0.000545554	0.02023459540845736
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.02023459540845736
3C SYNDROME	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.02023459540845736
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.02023459540845736
RING CHROMOSOME 12 SYNDROME	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.02023459540845736
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.02023459540845736
JAWAD SYNDROME	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.02023459540845736
CODAS SYNDROME	0.000545554	0.02023459540845736
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02023459540845736
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02023459540845736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.02023459540845736
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.02023459540845736
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02023459540845736
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.02023459540845736
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02023459540845736
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02023459540845736
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.02023459540845736
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.02023459540845736
AUSTRALIA ANTIGEN	0.000545554	0.02023459540845736
BARDET-BIEDL SYNDROME 2	0.000545554	0.02023459540845736
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.02023459540845736
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.02023459540845736
STEEL SYNDROME; STLS	0.000545554	0.02023459540845736
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.02023459540845736
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.02023459540845736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.02023459540845736
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000545554	0.02023459540845736
MIETENS SYNDROME	0.000545554	0.02023459540845736
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.02023459540845736
RAINE SYNDROME	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02023459540845736
ALG6-CDG	0.000545554	0.02023459540845736
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.02023459540845736
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02023459540845736
CULLER-JONES SYNDROME; CJS	0.000545554	0.02023459540845736
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.02023459540845736
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02023459540845736
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02023459540845736
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02023459540845736
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02023459540845736
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02023459540845736
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.02023459540845736
PELLAGRA-LIKE SYNDROME	0.000545554	0.02023459540845736
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.02023459540845736
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02023459540845736
OROTIC ACIDURIA	0.000545554	0.02023459540845736
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.02023459540845736
ALAZAMI SYNDROME; ALAZS	0.000545554	0.02023459540845736
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.02023459540845736
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.02023459540845736
OGDEN SYNDROME	0.000545554	0.02023459540845736
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.02023459540845736
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02023459540845736
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02023459540845736
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02023459540845736
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.02023459540845736
OPITZ G/BBB SYNDROME	0.000545554	0.02023459540845736
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.02023459540845736
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.02023459540845736
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.02023459540845736
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.02023459540845736
ZEBRA BODY MYOPATHY	0.000545554	0.02023459540845736
JOUBERT SYNDROME 21	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.02023459540845736
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02023459540845736
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02023459540845736
RIGID SPINE SYNDROME	0.000545554	0.02023459540845736
N SYNDROME	0.000545554	0.02023459540845736
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02023459540845736
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.02023459540845736
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.02023459540845736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.02023459540845736
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02023459540845736
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.02023459540845736
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.02023459540845736
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.02023459540845736
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02023459540845736
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.02023459540845736
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.02023459540845736
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02023459540845736
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.02023459540845736
XIA-GIBBS SYNDROME	0.000545554	0.02023459540845736
OKAMOTO SYNDROME	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02023459540845736
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.02023459540845736
SECKEL SYNDROME 8; SCKL8	0.000545554	0.02023459540845736
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.02023459540845736
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.02023459540845736
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02023459540845736
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.02023459540845736
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02023459540845736
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02023459540845736
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.02023459540845736
TRISOMY 17P	0.000545554	0.02023459540845736
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.02023459540845736
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.02023459540845736
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.02023459540845736
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.02023459540845736
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02023459540845736
NAVAJO NEUROHEPATOPATHY	0.000545554	0.02023459540845736
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.02023459540845736
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02023459540845736
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02023459540845736
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02023459540845736
TRISOMY 9P	0.000545554	0.02023459540845736
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02023459540845736
AL-RAQAD SYNDROME; ARS	0.000545554	0.02023459540845736
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.02023459540845736
ICF SYNDROME	0.000545554	0.02023459540845736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.02023459540845736
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.02023459540845736
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02023459540845736
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02023459540845736
AU-KLINE SYNDROME; AUKS	0.000545554	0.02023459540845736
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.02023459540845736
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.02023459540845736
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.02023459540845736
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02023459540845736
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.02023459540845736
NOONAN SYNDROME 9; NS9	0.000545554	0.02023459540845736
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.02023459540845736
MARINESCO-SJÃ–GREN SYNDROME	0.000545554	0.02023459540845736
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02023459540845736
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.02023459540845736
USHER SYNDROME TYPE 1	0.000545554	0.02023459540845736
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.02023459540845736
ATELOSTEOGENESIS TYPE III	0.000545554	0.02023459540845736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.02023459540845736
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02023459540845736
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02023459540845736
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.02023459540845736
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.02023459540845736
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.02023459540845736
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02023459540845736
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.02023459540845736
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.02023459540845736
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.02023459540845736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02023459540845736
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.02023459540845736
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.02023459540845736
JOUBERT SYNDROME 24	0.000545554	0.02023459540845736
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02023459540845736
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.02023459540845736
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02023459540845736
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.02023459540845736
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.02023459540845736
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.02023459540845736
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.02023459540845736
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02023459540845736
LATERAL MENINGOCELE SYNDROME	0.000545554	0.02023459540845736
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.02023459540845736
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02023459540845736
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02023459540845736
CHOPS SYNDROME; CHOPS	0.000545554	0.02023459540845736
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.02023459540845736
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.02023459540845736
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.02023459540845736
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.02023459540845736
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.02023459540845736
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000545554	0.02023459540845736
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.02023459540845736
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.02023459540845736
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.02023459540845736
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.02023459540845736
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.02023459540845736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02023459540845736
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.02008122827703871
SECONDARY SYRINGOMYELIA	0.000541419	0.02008122827703871
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.02008122827703871
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.02008122827703871
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.02008122827703871
WHIM SYNDROME	0.000541419	0.02008122827703871
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.02008122827703871
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.02008122827703871
GRISCELLI SYNDROME TYPE 2	0.000541419	0.02008122827703871
MOGS-CDG	0.000541419	0.02008122827703871
ALG9-CDG	0.000541419	0.02008122827703871
PARTINGTON SYNDROME	0.000541419	0.02008122827703871
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.02008122827703871
FAMILIAL THROMBOCYTOSIS	0.000541419	0.02008122827703871
MPDU1-CDG	0.000541419	0.02008122827703871
PORPHYRIA	0.000541419	0.02008122827703871
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.02008122827703871
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.02008122827703871
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.02008122827703871
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.02008122827703871
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.02008122827703871
ALG2-CDG	0.000541419	0.02008122827703871
PROTEUS SYNDROME	0.000541419	0.02008122827703871
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.02008122827703871
HADDAD SYNDROME	0.000541419	0.02008122827703871
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.02008122827703871
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.02008122827703871
RECURRENT ACUTE PANCREATITIS	0.000541419	0.02008122827703871
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.02008122827703871
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.02008122827703871
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.02008122827703871
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.02008122827703871
EPISODIC ATAXIA TYPE 3	0.000541419	0.02008122827703871
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.02008122827703871
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.02008122827703871
FETAL GAUCHER DISEASE	0.000541419	0.02008122827703871
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.02008122827703871
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02008122827703871
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.02008122827703871
CAMOS SYNDROME	0.000541419	0.02008122827703871
HEREDITARY COPROPORPHYRIA	0.000541419	0.02008122827703871
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02008122827703871
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.02008122827703871
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.02008122827703871
CENTRONUCLEAR MYOPATHY	0.000541419	0.02008122827703871
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02008122827703871
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.02008122827703871
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.02008122827703871
ASPARTYLGLUCOSAMINURIA	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.02008122827703871
MYASTHENIA GRAVIS	0.000541419	0.02008122827703871
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.02008122827703871
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.02008122827703871
ADDISON DISEASE	0.000541419	0.02008122827703871
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.02008122827703871
DERMOTRICHIC SYNDROME	0.000541419	0.02008122827703871
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.02008122827703871
NEVUS COMEDONICUS SYNDROME	0.000541419	0.02008122827703871
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.02008122827703871
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.02008122827703871
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.02008122827703871
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.02008122827703871
SYSTEMIC SCLEROSIS	0.000541419	0.02008122827703871
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.02008122827703871
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.02008122827703871
ONDINE SYNDROME	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.02008122827703871
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.02008122827703871
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.02008122827703871
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02008122827703871
SJÃ–GREN-LARSSON SYNDROME	0.000541419	0.02008122827703871
LASSA FEVER	0.000541419	0.02008122827703871
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.02008122827703871
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02008122827703871
LIPOID PROTEINOSIS	0.000541419	0.02008122827703871
LHERMITTE-DUCLOS DISEASE	0.000541419	0.02008122827703871
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02008122827703871
PFEIFFER SYNDROME TYPE 3	0.000541419	0.02008122827703871
MILLER-DIEKER SYNDROME	0.000541419	0.02008122827703871
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.02008122827703871
ISOLATED SPINA BIFIDA	0.000541419	0.02008122827703871
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.02008122827703871
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.02008122827703871
PORPHYRIA VARIEGATA	0.000541419	0.02008122827703871
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02008122827703871
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.02008122827703871
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.02008122827703871
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02008122827703871
RENPENNING SYNDROME 1; RENS1	0.000541419	0.02008122827703871
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.02008122827703871
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.02008122827703871
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.02008122827703871
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02008122827703871
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.02008122827703871
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.02008122827703871
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.02008122827703871
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.02008122827703871
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.02008122827703871
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.02008122827703871
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.02008122827703871
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.02008122827703871
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.02008122827703871
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.02008122827703871
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.02008122827703871
GURRIERI SYNDROME	0.000541419	0.02008122827703871
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.02008122827703871
POTOCKI-SHAFFER SYNDROME	0.000541419	0.02008122827703871
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.02008122827703871
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.02008122827703871
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02008122827703871
PALLISTER-KILLIAN SYNDROME	0.000541419	0.02008122827703871
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.02008122827703871
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02008122827703871
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.02008122827703871
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.02008122827703871
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.02008122827703871
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.02008122827703871
INCONTINENTIA PIGMENTI; IP	0.000541419	0.02008122827703871
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.02008122827703871
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.02008122827703871
XYLOSIDASE DEFICIENCY	0.000541419	0.02008122827703871
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.02008122827703871
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.02008122827703871
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.02008122827703871
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.02008122827703871
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.02008122827703871
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.02008122827703871
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.02008122827703871
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000541419	0.02008122827703871
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02008122827703871
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.02008122827703871
ATKIN-FLAITZ SYNDROME	0.000541419	0.02008122827703871
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02008122827703871
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.02008122827703871
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02008122827703871
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.02008122827703871
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02008122827703871
CLARK-BARAITSER SYNDROME	0.000541419	0.02008122827703871
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.02008122827703871
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02008122827703871
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.02008122827703871
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.02008122827703871
IMMUNODEFICIENCY 47	0.000541419	0.02008122827703871
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.02008122827703871
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.02008122827703871
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.02008122827703871
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.02008122827703871
HHHH SYNDROME	0.000541419	0.02008122827703871
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.02008122827703871
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.02008122827703871
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.02008122827703871
CRANIOSYNOSTOSIS 2	0.000541419	0.02008122827703871
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.02008122827703871
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.02008122827703871
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.02008122827703871
EPISODIC ATAXIA, TYPE 6	0.000541419	0.02008122827703871
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.02008122827703871
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.02008122827703871
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.02008122827703871
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.02008122827703871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.02008122827703871
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.02008122827703871
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.02008122827703871
NOONAN SYNDROME 7; NS7	0.000541419	0.02008122827703871
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.02008122827703871
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.02008122827703871
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.02008122827703871
PERRAULT SYNDROME 3	0.000541419	0.02008122827703871
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.02008122827703871
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.02008122827703871
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.02008122827703871
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.02008122827703871
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.02008122827703871
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02008122827703871
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.02008122827703871
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.02008122827703871
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.02008122827703871
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.02008122827703871
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.02008122827703871
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.02008122827703871
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.02008122827703871
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02008122827703871
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.02008122827703871
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.02008122827703871
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.02008122827703871
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02008122827703871
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.02008122827703871
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02008122827703871
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.02008122827703871
LATHOSTEROLOSIS	0.000541419	0.02008122827703871
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.02008122827703871
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.02008122827703871
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.02008122827703871
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.02008122827703871
ALZHEIMER DISEASE 3; AD	0.000541419	0.02008122827703871
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.02008122827703871
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.02008122827703871
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.02008122827703871
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.02008122827703871
LISSENCEPHALY 3; LIS3	0.000541419	0.02008122827703871
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.02008122827703871
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.02008122827703871
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.02008122827703871
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.02008122827703871
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02008122827703871
KLEEFSTRA SYNDROME	0.000541419	0.02008122827703871
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02008122827703871
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.02008122827703871
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02008122827703871
PITT-HOPKINS SYNDROME	0.000541419	0.02008122827703871
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02008122827703871
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.02008122827703871
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.02008122827703871
THYROCEREBRORETINAL SYNDROME	0.000541419	0.02008122827703871
THREONINEMIA	0.000541419	0.02008122827703871
TAY-SACHS DISEASE; TSD	0.000541419	0.02008122827703871
FILIPPI SYNDROME; FLPIS	0.000541419	0.02008122827703871
PARIETAL FORAMINA	0.000541419	0.02008122827703871
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.02008122827703871
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.02008122827703871
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.02008122827703871
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02008122827703871
STURGE-WEBER SYNDROME	0.000541419	0.02008122827703871
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.02008122827703871
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.02008122827703871
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.02008122827703871
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.02008122827703871
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.02008122827703871
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02008122827703871
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.02008122827703871
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.02008122827703871
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.02008122827703871
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.02008122827703871
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.02008122827703871
AUTISM	0.000541419	0.02008122827703871
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.02008122827703871
BANGSTAD SYNDROME	0.000541419	0.02008122827703871
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02008122827703871
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.02008122827703871
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.02008122827703871
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.02008122827703871
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.02008122827703871
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.02008122827703871
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.02008122827703871
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.02008122827703871
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.02008122827703871
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02008122827703871
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.02008122827703871
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.02008122827703871
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.02008122827703871
1P36 MICRODELETION SYNDROME	0.000541419	0.02008122827703871
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.02008122827703871
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.02008122827703871
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.02008122827703871
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02008122827703871
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.02008122827703871
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.02008122827703871
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.02008122827703871
PAPILLORENAL SYNDROME	0.000541419	0.02008122827703871
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.02008122827703871
CROUZON SYNDROME	0.000541419	0.02008122827703871
DARIER-WHITE DISEASE; DAR	0.000541419	0.02008122827703871
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.02008122827703871
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.02008122827703871
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.02008122827703871
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02008122827703871
EPILEPSY, READING	0.000541419	0.02008122827703871
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.02008122827703871
FLYNN-AIRD SYNDROME	0.000541419	0.02008122827703871
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02008122827703871
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.02008122827703871
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.02008122827703871
HUNTINGTON DISEASE; HD	0.000541419	0.02008122827703871
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02008122827703871
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.02008122827703871
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.02008122827703871
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02008122827703871
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02008122827703871
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.02008122827703871
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.02008122827703871
COHEN SYNDROME	0.000541419	0.02008122827703871
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.02008122827703871
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02008122827703871
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.02008122827703871
MARDEN-WALKER SYNDROME	0.000541419	0.02008122827703871
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.02008122827703871
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02008122827703871
OHDO SYNDROME	0.000541419	0.02008122827703871
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02008122827703871
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.02008122827703871
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.02008122827703871
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.02008122827703871
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02008122827703871
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02008122827703871
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.02008122827703871
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.02008122827703871
KEUTEL SYNDROME; KTLS	0.000541419	0.02008122827703871
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.02008122827703871
NEURAMINIDASE DEFICIENCY	0.000541419	0.02008122827703871
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.02008122827703871
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02008122827703871
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.02008122827703871
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.02008122827703871
RAMON SYNDROME	0.000541419	0.02008122827703871
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02008122827703871
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.02008122827703871
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.02008122827703871
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.02008122827703871
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.02008122827703871
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.02008122827703871
KIFAFA SEIZURE DISORDER	0.000541419	0.02008122827703871
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02008122827703871
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.02008122827703871
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.02008122827703871
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.02008122827703871
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02008122827703871
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.02008122827703871
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.02008122827703871
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.02008122827703871
DIAMINOPENTANURIA	0.000541419	0.02008122827703871
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.02008122827703871
EPILEPSY-TELANGIECTASIA	0.000541419	0.02008122827703871
FOUNTAIN SYNDROME	0.000541419	0.02008122827703871
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02008122827703871
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02008122827703871
FRYNS SYNDROME; FRNS	0.000541419	0.02008122827703871
GAPO SYNDROME; GAPOS	0.000541419	0.02008122827703871
BERNARD-SOULIER SYNDROME	0.000541419	0.02008122827703871
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02008122827703871
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.02008122827703871
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.02008122827703871
MOWAT-WILSON SYNDROME; MOWS	0.000541419	0.02008122827703871
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.02008122827703871
HYPER-BETA-ALANINEMIA	0.000541419	0.02008122827703871
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.02008122827703871
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.02008122827703871
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02008122827703871
HYPERPROLINEMIA, TYPE II	0.000541419	0.02008122827703871
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.02008122827703871
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02008122827703871
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.02008122827703871
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.02008122827703871
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.02008122827703871
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.02008122827703871
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.02008122827703871
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.02008122827703871
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02008122827703871
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02008122827703871
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.02008122827703871
EPENDYMOMA	0.000541419	0.02008122827703871
SUBEPENDYMOMA	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.02008122827703871
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.000541419	0.02008122827703871
MICROSPORIDIOSIS	0.000541419	0.02008122827703871
MOMO SYNDROME	0.000541419	0.02008122827703871
MOYAMOYA DISEASE	0.000541419	0.02008122827703871
MOYNAHAN SYNDROME	0.000541419	0.02008122827703871
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02008122827703871
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.02008122827703871
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.02008122827703871
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.02008122827703871
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.02008122827703871
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.02008122827703871
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.02008122827703871
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02008122827703871
COG5-CDG	0.000541419	0.02008122827703871
THANATOPHORIC DYSPLASIA	0.000541419	0.02008122827703871
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.02008122827703871
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02008122827703871
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.02008122827703871
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.02008122827703871
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.02008122827703871
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.02008122827703871
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.02008122827703871
AICA-RIBOSIDURIA	0.000541419	0.02008122827703871
CITRULLINEMIA TYPE I	0.000541419	0.02008122827703871
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.02008122827703871
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02008122827703871
ACROCARDIOFACIAL SYNDROME	0.000541419	0.02008122827703871
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.02008122827703871
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.02008122827703871
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.02008122827703871
CRIGLER-NAJJAR SYNDROME	0.000541419	0.02008122827703871
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.02008122827703871
EPISODIC ATAXIA TYPE 6	0.000541419	0.02008122827703871
HARROD SYNDROME	0.000541419	0.02008122827703871
HENNEKAM SYNDROME	0.000541419	0.02008122827703871
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02008122827703871
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02008122827703871
MOWAT-WILSON SYNDROME	0.000541419	0.02008122827703871
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.02008122827703871
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.02008122827703871
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.02008122827703871
CONGENITAL HYDROCEPHALUS	0.000541419	0.02008122827703871
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.02008122827703871
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.02008122827703871
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02008122827703871
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.02008122827703871
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.02008122827703871
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.02008122827703871
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02008122827703871
KABUKI SYNDROME	0.000541419	0.02008122827703871
SANJAD-SAKATI SYNDROME	0.000541419	0.02008122827703871
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.02008122827703871
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02008122827703871
CONGENITAL RUBELLA SYNDROME	0.000541419	0.02008122827703871
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.02008122827703871
CRONKHITE-CANADA SYNDROME	0.000541419	0.02008122827703871
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.02008122827703871
WORSTER-DROUGHT SYNDROME	0.000541419	0.02008122827703871
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.02008122827703871
CHIME SYNDROME	0.000541419	0.02008122827703871
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02008122827703871
GALACTOSIALIDOSIS	0.000541419	0.02008122827703871
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02008122827703871
GLIOBLASTOMA	0.000541419	0.02008122827703871
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02008122827703871
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.02008122827703871
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.02008122827703871
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.02008122827703871
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.02008122827703871
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.02008122827703871
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.02008122827703871
CLASSIC HOMOCYSTINURIA	0.000541419	0.02008122827703871
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.02008122827703871
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.02008122827703871
HYPERPROLINEMIA TYPE 1	0.000541419	0.02008122827703871
MALAN OVERGROWTH SYNDROME	0.000541419	0.02008122827703871
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.02008122827703871
HYPOPHOSPHATASIA	0.000541419	0.02008122827703871
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.02008122827703871
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.02008122827703871
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.000541419	0.02008122827703871
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.02008122827703871
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.02008122827703871
VIRAL HEMORRHAGIC FEVER	0.000541419	0.02008122827703871
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.02008122827703871
THYROCEREBRORENAL SYNDROME	0.000541419	0.02008122827703871
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.02008122827703871
PORENCEPHALY	0.000541419	0.02008122827703871
PROLACTINOMA	0.000541419	0.02008122827703871
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.02008122827703871
RAMON SYNDROME	0.000541419	0.02008122827703871
ISOLATED BILIARY ATRESIA	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02008122827703871
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.02008122827703871
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.02008122827703871
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.02008122827703871
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.02008122827703871
NOCARDIOSIS	0.000541419	0.02008122827703871
20P13 MICRODELETION SYNDROME	0.000541419	0.02008122827703871
15Q OVERGROWTH SYNDROME	0.000541419	0.02008122827703871
LUJO HEMORRHAGIC FEVER	0.000541419	0.02008122827703871
TETRASOMY 18P	0.000541419	0.02008122827703871
EBOLA HEMORRHAGIC FEVER	0.000541419	0.02008122827703871
RIFT VALLEY FEVER	0.000541419	0.02008122827703871
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.02008122827703871
FOUNTAIN SYNDROME	0.000541419	0.02008122827703871
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.02008122827703871
RENPENNING SYNDROME	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.02008122827703871
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.02008122827703871
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.02008122827703871
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.02008122827703871
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.02008122827703871
TAKAYASU ARTERITIS	0.000541419	0.02008122827703871
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.02008122827703871
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.02008122827703871
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.02008122827703871
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02008122827703871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.02008122827703871
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.02008122827703871
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.02008122827703871
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.02008122827703871
PSEUDO-TORCH SYNDROME 2	0.000541419	0.02008122827703871
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.02008122827703871
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.02008122827703871
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.02008122827703871
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.02008122827703871
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.02008122827703871
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.02008122827703871
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.02008122827703871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.02008122827703871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.02008122827703871
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.02008122827703871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.02008122827703871
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.02008122827703871
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02008122827703871
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.02008122827703871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.02008122827703871
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02008122827703871
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02008122827703871
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.02008122827703871
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.02008122827703871
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02008122827703871
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.02008122827703871
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.02008122827703871
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.02008122827703871
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02008122827703871
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02008122827703871
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02008122827703871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.02008122827703871
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02008122827703871
COWDEN SYNDROME 5; CWS5	0.000541419	0.02008122827703871
COWDEN SYNDROME 6; CWS6	0.000541419	0.02008122827703871
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02008122827703871
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02008122827703871
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.02008122827703871
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.02008122827703871
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02008122827703871
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.02008122827703871
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.02008122827703871
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.02008122827703871
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.02008122827703871
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.02008122827703871
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.02008122827703871
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02008122827703871
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.02008122827703871
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.02008122827703871
TENORIO SYNDROME; TNORS	0.000541419	0.02008122827703871
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02008122827703871
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.02008122827703871
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.02008122827703871
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.02008122827703871
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.02008122827703871
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.02008122827703871
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.02008122827703871
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.02008122827703871
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.02008122827703871
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.02008122827703871
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.02008122827703871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02008122827703871
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.02008122827703871
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.02008122827703871
WOLCOTT-RALLISON SYNDROME	0.000541419	0.02008122827703871
CRISPONI SYNDROME	0.000541419	0.02008122827703871
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.02008122827703871
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.02008122827703871
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.02008122827703871
KNOBLOCH SYNDROME	0.000541419	0.02008122827703871
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.02008122827703871
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.02008122827703871
ROSAÃ-DORFMAN DISEASE	0.000541419	0.02008122827703871
DISTAL MONOSOMY 3P	0.000541419	0.02008122827703871
DISTAL MONOSOMY 7Q36	0.000541419	0.02008122827703871
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.02008122827703871
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02008122827703871
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02008122827703871
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02008122827703871
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02008122827703871
DISTAL TRISOMY 15Q	0.000541419	0.02008122827703871
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.02008122827703871
DYSEQUILIBRIUM SYNDROME	0.000541419	0.02008122827703871
CENTRAL DIABETES INSIPIDUS	0.000541419	0.02008122827703871
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.02008122827703871
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.02008122827703871
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.02008122827703871
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.02008122827703871
FRONTAL ENCEPHALOCELE	0.000541419	0.02008122827703871
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.02008122827703871
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.02008122827703871
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.02008122827703871
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.02008122827703871
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.02008122827703871
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.02008122827703871
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.02008122827703871
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.02008122827703871
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02008122827703871
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.02008122827703871
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.02008122827703871
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02008122827703871
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.02008122827703871
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.02008122827703871
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02008122827703871
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02008122827703871
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.02008122827703871
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.02008122827703871
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.02008122827703871
BETA-MANNOSIDOSIS	0.000541419	0.02008122827703871
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.02008122827703871
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02008122827703871
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02008122827703871
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.02008122827703871
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.02008122827703871
C SYNDROME	0.000541419	0.02008122827703871
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02008122827703871
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.02008122827703871
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.02008122827703871
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.02008122827703871
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.02008122827703871
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.02008122827703871
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.02008122827703871
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.02008122827703871
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02008122827703871
RING CHROMOSOME 10 SYNDROME	0.000541419	0.02008122827703871
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.02008122827703871
